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ABSTRACT

Grigsby, Claude Ph.D., Biomedical Sciences Ph.D. program, Wright State university,
2013. A Comprehensive Tool and Analytical Pathway for Differential Molecular Profiling
and Biomarker Discovery

The key requirements to any empirically based study are to: (1) accurately
measure and then compare the collected results in determining the result of the
hypothesis being tested; and (2) collect a sample representative of the entities being
studied. To demonstrate that an informatics tool can be designed that provides spectral
registration, spectral and chromatographic alignment, visualization, and comparative
analysis for data generated from multiple analytical platforms, e.g., LC-MS and GC-MS,
the results and data analysis of five unique sets of experiments using a suite of novel
informatics tools are presented. Comprehensive and reproducible sample collection
techniques were developed concomitantly with the informatics tool and used in the
multiple, independent studies for the validation and further development of generated
software tools and approaches. Data from a dose-response study examining an organ
specific environmental toxicant exposure was analyzed using the prototype software
tool for discovery of LC/MS based metabolomic biomarkers. This data set served as
proof of concept in the development and illustration of the novel approach to spectral
iii

registration and visualization, and illustrates the rapid multi-sample analysis capability
of the informatics tool. A variety of additional studies focused on volatile biomarker
discovery, i.e., a murine model of infection to select agents, characterization of human
and murine urine as it ages, human markers of age and ethnicity in axillary odors, and
characterization of the binding between volatile ligands and murine major urinary
proteins aided in algorithm and interface development for GC/MS functionality
implemented in the developed software. The final phase of this work focused on
utilization of these analysis tools in combination with novel sampling techniques to
create an end-to-end discovery pipeline for large-scale small molecule and volatile
organic compound biomarker and differential profiling studies. This combination of
biologically and environmentally focused studies were successfully completed as final
proof of concept for this work and demonstrate the universal utility of the approach.
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CHAPTER I. INTRODUCTION

Overview
The key requirements to any empirically based study are to (1) accurately
measure and then compare the collected results in determining the result of the
hypothesis being tested, and (2) collect a sample representative of the entities being
studied. To address this requirement and its application to large scale analytical studies,
the research described here sought to develop and utilize a logically designed and
successfully implemented informatics tool for spectral registration, spectral and
chromatographic alignment, visualization, and comparative analysis in combination with
reproducible and comprehensive sample collection techniques. This work incorporated
multiple, independent studies for the development and validation of generated
software tools and approaches. To both answer active research needs and aid in the
development and illustration of the novel visualization and rapid multi-sample analysis
capability of the tool for discovery of LC/MS based metabolomic biomarkers, use of data
from a dose-response study examining environmental toxicant exposures is also
described. A variety of studies focused on volatile biomarker discovery were analyzed
to aid in algorithm and interface development for GC/MS analysis. Experiments
examined in support of this GC/MS analysis included: a murine model of infection to
1

select agents, characterization of human and murine urine as it ages, human markers of
age and ethnicity in axillary odors, and characterization of the binding between volatile
ligands and murine major urinary proteins (MUPs). The final phase of this work
demonstrates utilization of the analysis tools and workflow developed in combination
with both optimized and novel sampling techniques to create an end-to-end discovery
pipeline for large-scale small molecule and volatile organic compound biomarker and
differential profiling studies. A combination of biologically and environmentally focused
studies were assessed as final proof of concept for this analytical workflow and
demonstrate the universal utility of the approach. Successful completion of the pipeline
have facilitated and allowed the efficient and methodical analysis of multiple, largescale small molecule and volatile organic compound based biomarker discovery and
differential molecular profiling studies.

-Omic Profiling, Sampling Considerations, and Data Analysis Tools
A brief overview of the various nuances in systems biology data space, analysis
strategies, and sample collection considerations is required in order to adequately
frame development and application of the analytical pipeline for large scale profiling
studies which will be the focus of this proposal. Although the sciences of genomics and
proteomics are peripheral to much of this research, detail on all three is described as
2

the analysis approaches utilized for each are applicable to all, including metabolomics
and volatile profiling. It is worth noting that a rich variety of data analysis and data
mining software tools exist for genomics and proteomics in both open source format
and from a myriad of vendors, in sharp contrast to the lack of comparable capability in
the analysis of small molecule and volatile mass spectrometry-based differential
profiling studies. It was this lack in availability for small molecule metabolomic and
volatile informatics which served as the impetus and basis for much of the work
proposed below.

Gene Expression Profiling
The unique gene expression profiles in different cells determine their overall
functionality and phenotype. Phenotypic changes in response to perturbations resulting
from external chemical, biological and physical insults are mediated by and the
consequence of a concerted change in the expression of a large number of genes.
Therefore, the global gene expression profile represents a unique signature of a specific
cell state. By comparing gene expression profiles under different conditions, changes in
a gene expression profile may be used for classification and predictive models for a
variety of physiological and pathological states, as well as an indicator/predictor for the
host response to various external and internal stimuli or insults. As has been previously
3

demonstrated, gene expression changes elicited under different conditions are tightly
regulated and highly distinctive [1-6]. Genomics studies have generated useful data
highlighting the potential molecular mechanisms involved in many human diseases such
as cancer, heart disease, chronic inflammatory disease, etc. [1-4], as well as providing
better insights into the mode of action of different chemical toxicants [5, 6]. The DNA
microarray is a powerful and versatile tool for global gene expression profiling in
biomedical research, which can be used without well-defined underlying hypotheses. It
is therefore extremely useful in discovery-driven research in that it can provide
mechanistic insights into various physiological or pathological processes. The
expression profiles produced by microarray experiments represent the entire
transcriptome (or a selected portion of it, dependent on the coverage of the array) of
the cells or the tissue under a particular condition.
Analysis of DNA microarray data for biomarker discovery normally involves
feature selection and class discovery / class prediction using multivariate statistical
methods and/or pattern recognition techniques [7-9]. The objective is to identify
informative genes (i.e. a subset of genes that have undergone significant expression
changes) for a specific condition, such as the onset of a disease or exposure to a
chemical toxicant. Before the data analysis can be completed, the data set has to be
“preprocessed” [10, 11]. The first step of data preprocessing involves data
4

normalization to compensate for inter-array variations due to technical reasons. The
next step is to remove the genes with low-quality signals using statistical methods or
platform-specific algorithms [12]. This will assure that noise of the assay system can be
effectively filtered out. Finally, different data transformation techniques (e.g. logtransformation, mean-centering, etc) may be applied to facilitate data manipulation in
subsequent data analysis steps [13].
After the data is preprocessed, an exploratory visualization of the data may be
performed to examine the general grouping of the samples using an unsupervised
clustering method (e.g. hierarchical clustering, K-means clustering, self-organizing maps,
or principal component analysis) [14, 15]. Since these unsupervised methods do not
depend on any a priori assumption on class repartition, they will provide good
information regarding the effects of various variables on gene expression profiles, as
well as the presence of potential confounding factors. If the variable(s) of interest
appears to be the most dominant factor governing the gene expression profiles,
informative genes can readily be identified using traditional statistical methods (i.e.
student t-test, ANOVA, etc.) [16]. However if confounding factors with strong effects on
gene expression exist, algorithms developed for DNA microarray analysis (i.e.
Significance Analysis of Microarrays, Predictive Analysis of Microarray, supervised
pattern recognition techniques or machine learning algorithms) [17-21] will be needed
5

with appropriate re-sampling techniques for cross-validation [22, 23]. Despite the
inclusion of the cross-validation step, over-fitting of the model may still occur [24-26],
which will result in the selection of gene expression changes due to experimental
artifacts and noises. Therefore, validation using a fully independent data set should be
performed to ensure that the features selected are authentic informative genes.
Identification of informative genes will allow one to focus on a smaller subset of
genes with direct relevance to the problem of interest. For instance, genes that are
differentially expressed in test groups compared with control groups identified in DNA
microarray experiments can be further validated by analyzing in more detail and in
larger numbers of subjects using other technology platforms (i.e. quantitative real-time
RT-PCR) [27]. After additional testing and validation using computational and
experimental techniques, genes with the highest predictive power can be identified as
potential biomarkers for a specific physiological or pathological state.

Proteomic Profiling
Proteomics is the large-scale study of proteins, particularly their structures and
functions. The proteome in both humans and other higher life forms is orders of
magnitude more complex than the genome. While the genome is a rather constant
entity, the proteome differs from cell to cell and is constantly changing through its
6

biochemical interactions with the genome and the environment. One organism will
have radically different protein expression in different parts of its body, in different
stages of its life cycle and under different environmental conditions. Numerous post
translational modifications combined with amino acid substitutions have been reported
for the myriad of proteins coded by the genome. Discovering these differentially
expressed protein profiles along with their corresponding post translational
modifications (PTMs) is a critical step in understanding the molecular mechanisms
regulating function in both single cells and systemically. One of the core tasks assigned
to modern proteomics is the identification of differential biological markers that are
definitive for various states of organism health (i.e. disease vs. no disease, successful
treatment vs. unsuccessful treatment). Because levels of proteins in blood and urine
can reflect an individual’s state of health or disease, proteomics is especially suitable for
the identification of biomarkers [28]. The field of proteomics is still in development and
various approaches for separating and identifying proteins are being validated.
Additionally, separation and relative quantitation of complex protein mixtures remain
two of the most challenging aspects of proteomics, as will be discussed briefly below.
Sample preparation is a critical first step in any protein profiling experiment. Both the
source of the sample as well as the subsequent processing steps are greatly dependent
on the objectives of the study. Detecting and identifying all of the given proteins or
7

peptides in a complex biological mixture such as serum or tissue media is an extremely
difficult task due to both the wide dynamic range of protein expression levels (10 12
variance in concentration) and the differing physical characteristics and resultant
behavior of proteins during the separation process. In addition, in a mass spectral
analysis, the ion signal of low concentration analytes can easily become saturated by
highly abundant proteins, such as albumin, that are present in most raw biofluid
samples. This signal suppression compromises the identification of low abundant
proteins that are typically of highest interest in a biomarker discovery program. Multiple
commercially available devices are available to assist in the depletion of up to the 20
most abundant proteins from serum/plasma samples, thereby facilitating detection of
the less abundant proteins present. Other sample processing steps typically include a
combination of the following: solubilization, fractionation, equalization, precipitation,
desalting, and concentration.
Several techniques are currently in wide spread use for proteomic profiling.
Early mass spectrometry (MS) based biomarker profiling had previously been largely
focused on the Surface Extraction Laser Desorption/Ionization (SELDI) mass
spectrometry technology (see [29] for a comprehensive review). Early publications on
the success of this approach to detect disease fingerprints in complex samples were
received with some degree of skepticism and critique given subsequent failed attempts
8

to reproduce the results in addition to some obvious flaws in the protocol design [30].
The high dimensionality of the data, small sample sizes, lack of rigorous analysis of
technical and biological expressed. However, many reports employing SELDI time of
flight (TOF) MS-based approaches demonstrated success in the early detection of many
different cancers as well as other diseases [31-39]. 2-D gel electrophoresis, despite its
30 year history [40] and the many improvements that have been made to the
technology over the years [41-44], is still faced with problems in reproducibility and
comparability of individually generated gel images. Even with these challenges, many
laboratories have successfully used this approach to sort out differential changes in
complex protein mixtures and are routinely able to resolve over 1000 proteins on a
single gel, representing an adequate sampling of the expressed phenotype of a specific
sample. 2-D gel separation of proteins also allows for the easy detection of critical
posttranslational modifications and when performed on silver-stained gels, 2-D gel
electrophoresis is highly sensitive, detecting proteins down to the low ng levels. A new
approach introduced in the past several years is 2D difference in-gel electrophoresis
(2D-DIGE), a technique designed to minimize gel-to-gel variations. With 2D-DIGE,
protein extracts from two different samples are covalently labeled with two different
fluorescent dyes. The labeled samples are then mixed and subsequently separated on a
single 2DE gel. The gel is subsequently scanned at different wavelengths revealing
9

visually differentially expressed proteins as well as PTMs. Another recently emerging
and powerful approach employs Beckman-Coulter’s Proteome PF 2D system combined
with proprietary analogs [45-49]. This two dimensional separation of complex mixtures
is performed using isoelectric focusing (IEF) in the liquid phase (first dimension)
followed by reverse-phase high pressure liquid chromatography (RP-HPLC) in the second
dimension. On-line electro spray ionization (ESI) TOF mass spectrometry (see Figure 1)
enables detection even in third dimension [48]. The accompanying vendor supplied
software package generates color-coded protein maps that are easy to interpret and the
differential display of protein profiles enables clear visual differentiation of two
samples. Unfortunately the existing Beckman software suite does not allow for the
comparison of multiple samples as part of a larger study, requiring integration with
outside bioinformatics and statistical tools typically relegated to genomic array analysis.
To identify the chromatographically or electrophoretically separated proteins
once they are digested with a suitable enzyme (i.e. trypsin), the resultant peptides are
subjected to different MS techniques that may or may not include additional on-line
liquid chromatography such as a strong cation exchange column to separate peptides
before they enter the mass spectrometer.

10

Figure 1. ESI LC/MS acquired example of three dimensionality seen in
chromatographic / mass spectral data
[50]
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The MS techniques used for protein identification can be classified by the type of mass
spectrometer being utilized (quadrupole, TOF, ion trap, ion cyclotron resonance etc. as
well as hybrid instruments) as well as by the ionization technique used as a source and
interface with the HPLC. Electrospray ionization (ESI) and matrix assisted laser
desorption ionization (MALDI) are the two major techniques commonly used by
researches for protein profiling, with nano-spray ionization being basically a nano- or
reduced volume process of ESI. Nano-spray offers a higher sensitivity versus ESI due to
the increased efficiency of ionization [51, 52] and has become the defacto standard for
LC-MS based proteomics.
Other widely used approaches for protein profiling include techniques such as 2
dimensional liquid chromatography (2-D LC) and capillary electrophoresis [53]. In these
experiments the complex mixtures of proteins are digested with a suitable enzyme
(trypsin) followed by two physical separation techniques prior to ionization and MS
detection. 2-D LC systems typically consist of two columns, the first being a strong
cation exchange (SCX) column and the second a reversed phase (RP) or C18 column [5458]. The peptides are initially loaded onto the SCX column and are gradually eluted onto
the RP column using increasing salt steps with an aqueous/organic gradient between
increasing salt concentrations. This approach has facilitated unambiguous identification
of up to 1,500 proteins from one sample [59].
12

Metabolomic Profiling
Metabolomics is a rapidly growing field used to characterize the metabolic
profile of a specific tissue or biofluid. Metabolic profiling, originally pioneered by Jeremy
Nicholson, Elaine Holmes, and John Lindon at the Imperial College in London [60]
utilizing nuclear magnetic resonance (NMR) based analysis, has evolved to become one
of the most common applications of liquid chromatography mass spectrometry (LC-MS)
[61-63]. Metabolomics is an attractive approach to the study of time-related
quantitative multivariate metabolic responses to pathophysiological processes by which
biological and chemical agents, e.g., drugs, can cause perturbations in the
concentrations and flux of endogenous metabolites involved in critical cellular pathways
[64]. Thus, cells respond to toxic insult or other stressors by altering their intra-and/or
extra-cellular environment in an attempt to maintain a homeostatic intracellular
environment.
This metabolic alteration is expressed as a "fingerprint" of biochemical
perturbations characteristic of the type and target of a toxic insult or disease process
[65]. These metabolic alterations are often seen in body fluids as changes in metabolic
profiles in response to toxicity or disease, as the body attempts to maintain homeostasis
by eliminating substances from the body. Therefore, because many biofluids can be
easily obtained either non-invasively (urine) or minimally invasively (blood), they are
13

typically used in metabolomic studies [66]. Additionally, if a significant number of trace
molecules can be identified and monitored, the overall pattern produced may be more
consistent and predictive than any single biomarker [67], which would prove of great
value in the development of deployable devices for testing toxic or infectious exposures.
Volatile Organic Compound Based Metabolomic Profiling
A specific area of study within metabolomics is that focused on the volatile
metabolites. These volatile organic compound based metabolites, or VOC's, generally
have a boiling point less than 300°C and contain fewer than 12 carbon atoms[68].
Clinicians frequently associate peculiar body odors with a disease state and for several
disorders the odors are distinctive enough to be diagnostic [69, 70]. These odors are
often composed of “organic volatiles” such as nutrients, metabolic intermediates, waste
products, environmental contaminants, and other compounds of low molecular mass
involved in metabolism [68]. The concept of metabolic profiling was summarized by
Jellum et al. as follows, “it seems reasonable to assume that if one were able to identify
and determine the concentration of all compounds inside the human body, including
high molecular weight as well as low molecular weight substances, one would probably
find that almost every known disease would result in characteristic changes of the
biochemical composition of the cells and the body fluids” [71]. Metabolic disorders are
often characterized by the accumulation of a small number of metabolites in body
14

fluids, generally because a deficiency in enzymatic activity blocks the normal
biochemical pathway [72].
In the 1970’s, studies of volatile metabolites in human urine by Zlatkis and
Liebich [73, 74], composed of nearly 200 samples from adults were analyzed by gas
chromatography - mass spectrometry (GC-MS) and resulted in the identification of the
forty constituents listed in Table 1. The identities of these volatiles were subsequently
confirmed by comparing both the retention times and mass spectra of the compounds
with known standards. Key components found in the profiles of normal urines are
ketones (i.e. 2-butanone, 2-pentanone, and 4-heptanone), dimethyl disulfide, several
alkyl furans, pyrrol, and carvone. Pyrazines are present in trace quantities. During a
subsequent study performed in 1973 and 1980, mouse urine was shown to contain well
over 100 volatile components [75] similar to those in humans, and an additional study in
1989 [76] identified the compounds listed in Table 2 in an examination of dominant and
subordinate male mouse urine.
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Volatile Constituents in Human Urine
Diethyl ether (solvent)
2-Heptanone
3-Methyl-2-butanone
3-Methylcyclopentanone (tent)
2,3(?)-Dimethylfuran
Limonene
2,4-Dimethylfuran
2-n-Pentylfuran
2 2-Pentanone
4-Ethoxy-2-pentanone
2-Methyl-3-pentanone
Cyclohexanone
3-Methyl-2-pentanone
3-Octanone
4-Methyl-2-pentanone
5 Allyl isothiocyanate
1- Propanol
2-Octanone
2-Methyl-5-ethylfuran (tent)
Acetic acid
Dimethyl disulfide
6 Pyrrole
3-Hexanone
Benzaldehyde
3 2,3,5-Trimethylfuran
2,3-Butanediol
2-Hexanone
γ - Valerolactone
2-Methyl-1-propanol
α -Terpineol
5-Methyl-3-hexanone (tent)
γ - Hexalactone
3- Penten-2-one
Carvone
4-Methylpent-3-en-2-one (tent-)
δ - HexaIactone
4 4-Heptanone
9 Dimethyl sulfone
Cyclopentanone
4-Methyl-5-hydroxyhexanoic acid
2-Methyltetra hyd rofu ran-3-one (tent)
Lactone(tent)
3-Heptanone
ρ - Cresol B

Table 1. Volatile Constituents in Human Urine (Adapted from [77]).
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Volatile Compounds in Urine of ICR/ALB Male Mice
Class of compounds
Structure
Dihydrofurans
mol wt 126
mol wt 126
mol wt 126
Ketones
2-Heptanone
5-Heptene-2-one
4-Heptene-2-one
3-Heptene-2-one
6-Methyl-6-hepten-3-one
6-Methyl-5-hepten-3-one
Acetophenone
Acetates
n-Pentyl acetate
2-Penten-l-yl acetate
Dehydro-exo-brevicomin
2-(sec-butyl)-4 ,5-dihydrothiazole
Sesquiterpenes
β-Famesene
α-Farnesene

Table 2. Volatile Compounds in Dominant and Subordinate Male Mouse Urine (Adapted
From [76]).
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Approaches to Volatile Sampling
Volatile sampling may be performed using a variety of approaches, each of which
come with their own advantages and disadvantages in such areas as analyte sensitivity
and selectivity of volatiles sampled, form factor (sampler/sensor footprint), and
time/cost of analysis. Additional consideration must be given to any volatile study to
determine the best approach with the principal concerns being: experimental
scale/number of samples, are the compound(s)/subspecies of interest known, and is
absolute quantitation required. To understand the implications of the above in the realworld applications described and proposed below, a brief overview of volatile sampling
techniques is required.
The majority of air sampling for volatiles performed in both the laboratory
setting and environmental field monitoring is a variant of a "grab" sample. Grab samples
consist of a single, finite time slice of the atmosphere captured during the sampling time
period and provide the concentration of a volatile mixture for only the actual time slice
comprising the collection (i.e. a still picture versus video). The time slice may be
extended through the manipulation of flow rates across a sensor or modifying diffusion
to a media, but inevitably are limited in that the reported concentrations are a time
weighted average of the time of collection, which does not allow for discrimination of
short duration increases or decreases in analyte concentration. Time-series collections
18

through the sequential acquisition of grab samples is possible as is the continuous,
"real-time" monitoring of a volatile sample space through solid state sensors. Both of
these approaches have limitations, with space, power, and increased analysis
requirements being principal concerns for the time-series grab samples and limited
analytical resolution and discrimination being foremost for real-time sensors (i.e. only
good for a given analyte or analyte sub-set). Below is a brief description of some of the
most commonly used volatile sampling techniques along with their associated
advantages and disadvantages.
The gold standard for volatile "grab" sampling is the summa canister, a stainless
steel electro-polished (or "summa" polished) passivated vessel, generally in a spherical
or cylindrical format. Summa canister are available in a variety of sizes (100ml to 10L),
contain a valve and gas tight fitting for sample inlet, and are "re-conditioned" (cleaned)
and evacuated prior to collection. Additional accessories which can be used in
conjunction with summa canisters to allow for time-weighted, longer duration
collections are flow controllers and critical apertures/orifice assemblies, and analog
gauges. For typical air grab sampling using summa canisters, the summa canister valve
is opened and the canister is left in a designated area for a period of time to allow the
surrounding air to fill the canister and achieve a representative sample. The valve is then
closed and the canister is sent to a laboratory for analysis. Summa canisters are typically
19

analyzed via GC/MS according to the EPA's guidelines for air, such as methods TO-14
and TO-15 [78] and are the only way to trap the lightest of the freons and inorganic
(permanent) gases such as O2, O3, CO2, SO2, NO2, etc. However, compared to other grab
sampling techniques, summa canisters are more expensive, have a large physical and
logistical footprint, require manual sampling and additional high-cost equipment to be
compatible with most GC systems, and are limited in their volatile capture range to
compounds with 10 carbons or less [79]. Another common approach to volatile grab
sampling are gas sampling bags such as the Tedlar® bag. Tedlar® bags require either
manual (i.e. hand pump) or active pumping of air using a portable sampling pump into
these relatively less expensive bags which can then be returned to the lab for analysis.
Analysis is generally performed either by injecting the air in the bag directly into a
sorptive device to concentrate low levels of VOCs, followed by desorption into the
GC/MS, or by aspiration and injection via a gas tight syringe into a sealed headspace vial
(less sensitive) and analysis by GC/MS. Principal limitations for gas bag sampling are
limited sample stability and associated difficulties in sample transport/shipment, large
sampling footprint, and volatile condensation on the bag surface requiring heating
immediately prior to analysis.
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Another approach to air sampling is the passive collection of volatiles onto a
sorbent media. Passive sampling is widely used in both the industrial and environmental
setting and is particularly useful in many applications that are space limited and/or
require long term monitoring, such as in workplace personnel assessments. The devices
used for passive sampling are usually based on diffusion through a well-defined
diffusion barrier or permeation through a membrane. The analyte concentrations
obtained using the passive samplers are a time weighted average, and are limited to the
capture range of the media utilized. One of the most commonly utilized passive
samplers is the badge type device, which is commercially available from numerous
manufacturers such as 3M and SKC [80]. These devices do not require any active
sampling pumps but generally need exposure to the sample air for considerably longer
times (4 hrs or more) for low level detection. Quantitation requires calculation based
upon published uptake rates for each individual volatile on a given passive sampler and
both open source literature [81] and recent consultation with NIOSH have shown that
this sampling approach has been proven less reliable and reproducible for quantitative
studies than actively, pumped samples.
One of the most commonly used passive media formats is solid phase
microextraction, or SPME. SPME, which has other commercial analogues such as SPE-td
(or SBSE aka “Twister”) is a licensed, passive sampler available from Supelco (Bellefonte,
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PA). Most GC sample preparation procedures using based on solvent extractions have
been time-consuming, labor intensive, multi-stage operations. All of these steps,
especially concentration via solvent evaporation, introduce errors and losses, especially
when analyzing volatile compounds. Additionally, waste solvent has to be disposed of,
adding to the expense of the procedure. Many of these limitations have been reduced
through the use of solid phase extraction (SPE), but this technique is still time
consuming and generally requires a concentration step. Solid phase microextraction
(SPME), was invented by Pawlisyzn at the University of Waterloo (Ontario, Canada) in
1989 [82, 83], and addresses these limitations by integrating sampling, extraction,
concentration, and sample introduction into a single step. SPME utilizes a short, thin,
solid rod of fused silica (typically 2 cm long and 0.11 mm OD) coated with an adsorbent
polymer. The fiber is the same type of chemically inert fused silica used to make
capillary GC columns and is stable at high temperatures [84]. The SPME extraction
consists of two processes: analytes partition between the sample and the fiber coating;
and the concentrated analytes desorb from the coated fiber to an analytical instrument.
SPME extraction is a complex multiphase equilibrium process. An extraction can be
considered complete when the concentration of analytes has reached distribution
equilibrium between the sample and coating (amount extracted is independent of
further increases in time). The higher the distribution constant of a compound, the
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higher the affinity of that compound for the SPME fiber coating [85]. In general, the
distribution constant for an analyte increases with increasing molecular weight and
boiling point. The equilibrium conditions can be described as:

where n is

the amount extracted by the coating, Kfs is a fiber coating/sample matrix distribution
constant, Vf is the fiber coating volume, Vs is the sample volume, and C0 is the initial
concentration of a given analyte in the sample [85].
There also exists a linear relationship between the amount of the analyte on the
fiber extracted and its initial concentration Cs,0 in the sample if the extraction time is
long enough for equilibration, the dynamic range of the method is not exceeded and all
other experimental conditions (sample composition, temperature, volumes of sample,
and headspace) are held constant [85]:

n = const x Cs,0 where

The above equation still holds true if the extraction is interrupted after a
constant time before the equilibrium is attained [86]. In SPME, detection limits depend
on the distribution constants and polarity of the analytes but are often in the ppt. For
example, with a 100 um polydimethylsiloxane (PDMS) fiber, nonpolar compounds with
high distribution constants have lower minimum detection limits than more polar
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analytes with lower distribution constants. Branched aromatic compounds and
chlorinated alkenes exhibit the lowest detection limits [87].
As the extremely volatile compounds can begin to leave the fiber before the
sample is injected, it is best to minimize the time between extraction and desorption
and to maintain consistent timing for each step. Some of the advantages of SPME over
other approaches such as summa canisters are: it is a passive sampling technique and
takes only a few minutes for equilibration; the “clean” sampling matrix provides an
accurate volatile baseline; lower sample cost and smaller footprint versus a summa
canister; and will detect material with higher boiling points than benzene, like engine or
mineral oil hydrocarbons [88]. Significant downsides to SPME are that sufficient analyte
may not be absorbed by the SPME fiber for quantitation if the total concentration is
very low, SPME volatile mixture capture is limited low sample capacity and competitive
displacement, there is no easy way to automate analysis for high volume testing, and
sample breakthrough/loss becomes a large concern for extended exposures or in a high
flow environment and limits stability on fiber. Additionally, only one analysis per
sampling event is possible as the fiber is completely reconditioned after each injection.
With other techniques listed above (i.e. summa canister and gas bag), the analyst may
perform multiple trials / sample injections into GC/MS with just one sampling event. For
the field sampling pipeline proposed in this study, the fibers would require transport at 24

4°C. Even under these conditions, prior experience in our laboratory [89] has
demonstrated that it is likely not possible to store the SPME fiber for 3 days or more
post sampling and recover highly volatile organic compounds such as chloromethane,
but the technique does remain viable for less volatile compounds (i.e. naphthalene and
dichlorobenzenes). It must also be noted that after discussions with scientists directly
involved with development of SPME in the laboratory of Dr. Janusz Pawliszyn [90], the
use of sorption tubes, described below, is certain to be more quantitatively accurate
than SPME due to the competitive binding nature and limited surface area of the SPME
fibers.
Arguably the most versatile and accurate approach to unknown atmospheric
mixtures characterization are the active sampling techniques. Active sampling requires
forced airflow through the collection media using either a pump or in-line series/parallel
flow. The most commonly utlized active media format in environmental monitoring for
this purpose is the thermal desorption (TD) tube.
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Although TD tubes may be used in the passive role (see below), they are primarily used
in conjunction with an actively pumped system. These tubes are analogous to thermal
desorption traps used in GC/MS to concentrate VOCs in a headspace analysis or trap
columns used in liquid chromatography. TD tubes allow for collection of volatiles by
channeled air flow though the capture packing material using miniaturized sampling
pumps at the testing site. The TD tubes are then either thermally desorbed (i.e. via
commercial autosamplers) or solvent desorbed for analysis. When utilized for passive
sampling, as gases will diffuse in (and out of) both ends of the tube, all the passive
sampling work is generally done with a single sorbent bed in the tube. Doing this limits
the boiling point range covered, making this method somewhat constrained in that the
analyte being measured should be previously determined. As diffusion drives this flow,
breakthrough is not a concern, however, low boiling materials may diffuse back off of
the tube (i.e., diffusion is a two way process). This is particularly important if the nature
of the gas being monitored changes and has a lower concentration of the target analyte
than the original gas. Depending on the duration for which the sample air is pumped,
sorption tubes can either be considered as grab sampling or time weighted average
sampling (i.e. ~5mins can be considered as grab sampling vs. 4hrs at low flow rates
considered as time weighted average sampling). One feature which contributes greatly
to the use of TD tubes for unknown or mixtures detection is the availability of multi26

Figure 2. Multiple sorbent beds present in tri-bed thermal desorption tube utilized
for EPA Method TO-17.
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phase packing materials capable of capturing a wide range of volatiles, such as in the
tribed tubes recommended for use in EPA method TO-17 ("Air Toxics"), example shown
in Figure 2. It is due to this versatility and spectrum of commercially available sorbents
that TD tube use is widely reported for breath sampling for biomarker discovery [91,
92].

Data Analysis
To fully appreciate the parallels between GC-LC/MS and the other -omics data
sets described above and the associated requirements for post-acquisition analysis, a
basic understanding of the raw chromatographic and spectral data obtained is needed.
Using the example of an acquisition performed by GC/MS, a typical sample consisting of
an unknown mixture of interest is introduced into the heated sample injection port (i.e.
via SPME) and flushed by an inert carrier gas, generally helium, onto the head of the
capillary column. The columns used by our laboratory are fused silica open tubular
(FSOT) format columns and consist of a fused-silica capillary tube whose walls are
coated with liquid stationary phase. Without delving too deeply into issues surrounding
stationary phase selection, thickness, and their relevance to the principals of optimized
theoretical plate separation, column types are determined based on the physical
property selected as the best candidate for separation of the individual components of
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the mixture of interest (i.e. polarity or hydrophobicity) as well as the sample capacity
required. As the complex mixture is pushed through the column and interacts with the
bound stationary phase, individual components are pulled apart based on the physical
property of the column type, and under optimal conditions, elute as discrete, Gaussian
peaks into the detector (mass spectrometer) over a chromatographic time scale,
generally measure in minutes, giving the first dimension of each sample run. For the
two, additional sample dimensions, we must look at the detector utilized, the mass
spectrometer. According to Silverstein [93], the concept of mass spectrometry is
relatively simple: a compound is ionized (i.e. via electron impact, or EI, in the case of
GC/MS), the ions are separated on the basis of their mass/charge (m/z) ratio, our
second dimension, and the number of ions representing each m/z unit is recorded as a
spectrum. The intensity of each individual ion can be correlated to relative intensity,
and it is this intensity which gives us our third dimension. When all three dimensions are
viewed either as a heat map or surface (Figure 3), the data feature similarities between
GC-LC/MS, genomic (i.e. gene-chip), and proteomic (i.e. 2D-SDS PAGE gels) become
readily apparent. Analysis issues such as image alignment, feature registration, data
visualization, and differential profiling are all required, and lessons learned in the more
mature fields, such as genomics, are directly applicable to the analysis of metabolomic
data.
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Figure 3. Chromatographic and mass spectral data showing the three axes of time, m/z,
and intensity and example analysis techniques utilized in differential molecular profiling
studies.
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CHAPTER 2. RESEARCH QUESTION AND DESIGN

Problem Statement
To illustrate the data gap in both sampling and analyzing real-world needs in
molecular profiling, following is a widely reported issue identified with USAF aircraft
where numerous knowledge and capability gaps exist in the molecular characterization
of the operational environments faced by today’s Airmen. In 2011, the entire F-22 fleet
was grounded for nearly 5 months due to a series of incidents where pilots had
experienced unexplained symptoms such as shortness of breath, disorientation,
confusion, and headache, among other symptoms. This has led to a myriad of formal
investigations that have identified aircraft systems limitations as well as a need to
improve our analytical toolset and understanding of the environments encountered in
the F-22 and other high performance aircraft, and their effects on the humans operating
them. In the midst of these high profile investigations, ground maintenance personnel
have also had a series of incidents where they have experienced symptoms such as
dizziness, headache, and nausea while performing engine ground runs. These incidents
have had a similar response effort undertaken for them where possible, to include
environmental samples out of the cockpit air supply, but have found no specific cause
from that methodology. Unfortunately, the response methodology was tailored to in31

flight emergencies, and given that testing capabilities are more numerous on the
ground, this issue has not been explored as much as possible. A comprehensive
exploration of the associated chemical environments will require both the application of
existing sampling tools (described above), development of novel analysis techniques,
and improvements in large scale environmental differential profiling. Additionally,
extensive evidence exists on the uniqueness and dynamics of molecular, and particularly
mass spectral, signatures of liquids and gases for use in identification of materials,
phenotypic states, and environmental conditions. These operational concerns must be
addressed through the development and application of both novel sampling tools and
novel applications of available media for the detection and identification of potential
contaminants and other performance degrading conditions experienced both on the
ground and in-flight. The scope and scale of these studies will also be limited due to the
availability of informatics tools capable of the 1000's of generated sample sets. Current
LC/MS and GC/MS systems typically consist of a system of specialized instrumentation
with customized support software. This software is generally proprietary, being
supplied by the instrument manufacturer, and is primarily designed to facilitate user
interaction with the analytical hardware. Most manufacturers also market add-on
commercial software packages for the analysis of the results of LC/MS and GC/MS
experiments, which provide a limited tool set for a specific type of data analysis (i.e.
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proteomic or metabolomic), generally with a focus on pharmaceutical development
needs, and which cannot be readily modified or added to by the end-user as various
study needs arise. For larger molecular profiling and biomarker discovery studies, such
as the LC-GC/MS efforts undertaken by our laboratory, none of the software solutions
reviewed [94-99] offer the ability to compare multiple time point and exposure groups,
or handle data sets in significant sample numbers. Due to the need to implement a
wide spectrum of differential algorithms required for individual studies as well as the
undocumented "black box" nature prevalent in much of the vendor and recently
available open source tools/algorithms (possibly inducing unknown bias in obtained
results), creation of a novel, modular informatics tool set allowing processing of the raw,
chromatographic and spectral data was required.

Hypothesis
The core hypothesis tested during the course of this work is that an informatics
tool can be designed that provides spectral registration, spectral and chromatographic
alignment, visualization, and comparative analysis for data generated from multiple
analytical platforms, i.e. LC-MS and GC-MS. Comprehensive and reproducible sample
collection techniques were developed concomitantly with the informatics tool and used
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in multiple, independent studies for the validation and further development of
generated software tools and approaches.

Technical Objectives
As stated earlier, the key requirements to any empirically based study are to (1)
accurately measure and then compare the collected results in determining the result of
the hypothesis being tested, and (2) collect a sample representative of the entities being
studied. For measurement in metabolomic studies focused on volatile and small
molecule profiling (i.e. 41-1000 m/z), the standard method of approach is GC or LC/MS
with associated support software. In addition to the proprietary instrument driver
software supplied by the instrument manufacturer , most GC-LC/MS manufacturers also
market add-on commercial software packages for the analysis of the results of MS
experiments, which are meant to fill the gap in data processing and provide a very
specific type of analysis (i.e. proteomic or metabolomic for drug discovery/metabolism)
and cannot be modified or added to by the end-user. For larger metabolomic profiling
studies, such as the efforts completed in support of this work, none of the software
solutions available at the time this effort was initiated offered the ability to compare
multiple sample groups and handle data sets in significant sample numbers (i.e. >500
samples). This bottleneck in data handling was the impetus for the development of the
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informatics tools generated. The second requirement for the creation of this analytical
pipeline was the design and execution of novel capture techniques and/or the downselection of the best commercially available (if experimental criteria are met), with a
focus on collecting comprehensive samples to meet the need for the complete
characterization of the samples/environments of interest. In summary, the overall
objectives of this work were to develop and implement an implement an analytical
pipeline to: (1) identify differential molecular signatures and biomarkers of materials,
phenotypic states, environmental conditions, and individual/group differences; (2)
enhance existing mass spectral differential profiling capability, allowing for optimally
targeted unknown compound identification for potential subsequent incorporation into
sensor platforms; and (3) conduct associated field sampling in support of operational
needs. We achieved the objectives of this work through pursuit of the following three
specific aims.

Specific Aim 1
To test the hypothesis that the design and utilization of a novel, prototype
software tool for feature registration, and spectral and chromatographic alignment will
facilitate analysis of large scale studies for LC/MS based biomarker discovery and small
molecule profiling, and allow the ability to visualize the data for a global view of an
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entire experiment, while still maintaining the ability to focus on individual metabolites
and spectra for subsequent identification. In support of this aim, a prototype software
tool (described below) was designed in Matlab 2010a (The MathWorks Inc., Natick, MA)
for LC/MS based spectral registration and alignment. A preliminary data set from a
biomarker discovery experiment to identify low lever markers of organ specific damage
was utilized for this proof of concept study. LC/MS based metabolomic analysis was
performed using the Waters Acquity® ultra-performance liquid chromatograph coupled
to a Waters QToF® hybrid tandem quadrupole/time of flight mass spectrometer
equipped with a Lockspray electrospray source operating in positive ion mode. The
resulting spectra were analyzed using this prototype software tool.

Specific Aim 2
To test the hypothesis that the combination of a suite of basic comparative
algorithms, logical operators, and statistical filters in conjunction with an integrated set
of machine learning tools for feature down-selection will allow for the efficient analysis
of GC/MS based spectral data to support volatile biomarker and gas phased-differential
molecular profiling studies. In support of this aim, modifications and enhancements
were completed on the prototype software tool created in Aim 1 to allow for the
visualization and analysis of GC/MS acquired experimental data in support of multiple
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VOC based biomarker and molecular profiling research. Initial GC/MS based
metabolomic analysis were performed using a Thermo Scientific (Waltham, MA) Trace
GC Ultra® gas chromatograph interfaced to a Thermo Triplus® autosampler configured
for automated SPME headspace sampling and in-line with a Thermo DSQII® single
quadrupole mass spectrometer. Further validation of this tool and approach to
analytical studies were conducted on a variety of volatile profiling studies, to include
phenotypic characterizations of a urine murine model, as well as other data sets,
including environmental studies, to demonstrate versatility of the approach.

Specific Aim 3
To test the hypothesis that the creation and execution of a logically designed
work flow for large-scale analytical studies in differential molecular profiling, essential in
both environmental and biological screening studies, requires not only an efficient data
analysis pipeline, but also the design and execution of novel capture techniques focused
on collecting comprehensive samples, allowing for the complete characterization
necessary. Studies which require complete characterization of an unknown, whether it
is biologically derived, such as human breath, or environmental, as in the case of fighter
cockpit air, necessitate varied approaches to collection for accurate and broad-spectrum
capture of all potential molecular species present. In support of this aim, a thermal
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desorption tube based approach to sample collection for in-flight, pilot air supply was
performed with follow-on analysis being completed utilizing a modified version of EPA
Method TO-17 for monitoring VOCs via automated, cryogen-free TD using a Markes Intl
TD100® in line with a Thermo Scientific Trace GC Ultra® and ISQ® single quadrupole
mass spectrometer. The thermal desorption GC/MS system was calibrated with a
standard of target 65 VOC analytes, including selected aliphatic and aromatic
hydrocarbons, ketones, alcohols, esters and halogenated organics such as Freons and
chlorinated solvents. In addition to the target compound analysis, we identified
detected compounds and estimated quantities for all major non-target chromatographic
peaks using mass spectral library search procedures.

Experimental Design
As the goal of this work was to design and implement an end-to-end sample
collection to results pipeline, to include a prototype software tool, incorporation of
multiple, independent studies were required for development and validation of
generated tools and approaches. The principal bottleneck to any study of this type is the
data processing and analysis, thus the first aim was to address this through the
development of a prototype spectral analysis platform. To both answer an active
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Aim 1

Focus

Data Type(s)

Supporting Experiment(s)

Foundational software framework to include

LC/MS

Small molecule biomarker discovery in F344 model for low level

spectral registration and alignment
Aim 2

GC/MS data functionality - chromatographic time

organ selective toxin exposure
GC/MS

Characterization of the binding between volatile ligands and

binning and fold change

murine major urinary proteins
Volatile characterization of murine urine as it ages
Volatile characterization of human urine as it ages

Data filtering and normalization techniques

GC/MS

Human volatile markers of age and ethnicity in axillary odor profiles

Novel hybrid evolutionary classifier for biomarker

GC/MS

Murine model of urine based volatile makers of infection to select

discovery
Aim 3

Novel sampling technique for comprehensive

agents
GC/MS

In-flight air quality assessment of the combat air fleet using a novel

assessment of volatile contaminants

sampling approach

Table 3. Foci, data types, and major experiments completed in support of aims.
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research need and aid in the development and illustration of the novel visualization and
rapid multi-sample analysis capability of the tool for discovery of metabolomic
biomarkers, use of data from a dose-response study examining environmental toxicant
exposures was performed.
The next goal of this study was to expand both the capabilities of the informatics
tools and develop a suite of optimized techniques for analysis of volatile based
metabolites. Using the same approach as for the LC/MS data analysis, a variety of
studies focused on volatile biomarker discovery were processed with the enhanced
informatics tool to: aid in algorithm and interface development; provide validation of
generated results; and to prove its utility. To demonstrate the various processing,
algorithmic, and data filtering requirements addressed, a wide range of study types
were processed. Experiments examined in support of this aim included: a murine model
of infection to select agents, characterization of human and murine urine as it ages,
human markers of age and ethnicity in axillary odors, and characterization of the
binding between volatile ligands and murine major urinary proteins (MUPs).
The final goal of this work was to utilize the analysis tools and workflow
developed in the first two aims in combination with both optimized and novel sampling
techniques to create an end-to-end discovery pipeline for large-scale small molecule
and volatile organic compound biomarker and differential profiling studies. An
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environmental health and safety focused study of the cockpit atmosphere was assessed
as final proof of concept and demonstrate the universal utility of the approach.
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CHAPTER 3. FOUNDATIONAL SOFTWARE FRAMEWORK

Overview
The goal of this work was to design and implement a prototype software tool for
the visualization and analysis of small molecule metabolite GC-MS and LC-MS data for
biomarker discovery. The key features of the Metabolite Differentiation and Discovery
Lab (MeDDL) software platform [100] include support for the manipulation of large data
sets, tools to provide a multifaceted view of the individual experimental results, and a
software architecture amenable to modification and addition of new algorithms and
software components. The MeDDL tool, through its emphasis on visualization, provides
unique opportunities by combining the following: easy use of both GC-MS and LC-MS
data; use of both manufacturer specific data files as well as netCDF (network Common
Data Form); preprocessing (peak registration and alignment in both time and mass);
powerful visualization tools; and built in data analysis functionality.
To illustrate the novel visualization and rapid multi-sample analysis capability of
MeDDL for discovery of metabolomic biomarkers, data from a portion of a study
examining environmental toxicant exposure has been selected. Environmental
exposures to toxins as well as therapeutic interventions often cause
nephrotoxicity[101]. An expanded list of metabolites indicating kidney damage would
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be immensely helpful in the monitoring of renal conditions after exposure to external
toxicants, not only in pharmaceutical drug safety evaluations and clinical studies, but
also in the occupational and military operational setting.
As reported previously by our group [102], D-serine is ubiquitous in human
plasma and composes up to 3% of total plasma serine level in humans, with plasma Dserine elevations observed in chronic renal failure, suggesting elimination by the kidney
is responsible for control of D-serine concentrations. D-serine is reabsorbed in the pars
recta region of the rat proximal tubule and subsequently metabolized by D-aminoacid
oxidase (D-AAO), to produce α–keto acid, ammonia, and hydrogen peroxide [103, 104].
Other research has indicated that metabolism of D-serine by D-AAO is causative for
initiation of toxicity in the kidney, with elevated levels generating selective necrosis to
the pars recta region of the renal proximal tubules in the rat[105]. The choice to use the
D-Serine model was made in order to reveal both early and sensitive biomarkers for
epithelial cell injury in the kidney.

Urine Samples and Materials
Animal use in this study was conducted in accordance with the principles stated
in the Guide for the Care and Use of Laboratory Animals, National Research Council,
1996, and the Animal Welfare Act of 1966, as amended. Male Fischer 344 rats weighing
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222–258 g were obtained from Charles River Laboratories. Groups of five animals
received a single intraperitoneal (IP) dose of d-serine at a dose of 5, 20, or 500 mg/kg (or
vehicle only - 0.9% saline solution). Food (Purina Certified Rat Chow # 5002) and water
was available for all animals ad libitum. The housing environment was maintained on a
12 hour light-darkness cycle at 25°C, and all animals were examined by Vivarium
personnel twice daily. Urine samples were collected cold using plastic 50 mL conical
tubes containing 1.0 mL of 1% sodium azide maintained at 6-10°C using I-Cups
(Bioanalytical Systems, Inc.; stored at -80°C prior to use) 24 h prior to dosing and daily
thereafter, generating five twenty-four hour intervals (0, 24, 48, 72, and 96 hours postdosing). The urine was then frozen at -20°C and thawed on ice prior to analysis. For the
D-serine exposure set described, 104 individual samples were processed by aliquoting
1.0 ml of urine into a 2 ml centrifuge tube and centrifuged at 13,000 RPM for 5 minutes
at 5°C to remove debris. The supernatant was removed using a 1 mL tuberculin syringe
and filtered through a 0.2 μm PTFE syringe filter disc prior to aliquot transfer to two
Waters Corp. Total Recovery Vials and subsequent duplicate testing.

Instrumentation and Methods
The LC/MS system utilized for sample analysis was a Waters Q-ToF Micro in line
with a Waters Acquity UPLC. The source temperature was set to 130°C, a desolvation
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gas temperature of 320°C and a desolvation gas flow of 600 l/h were employed. The
capillary voltage was set at 3.2 kV for both positive and negative ion mode analysis. A
scan time of 0.4 s with an inter-scan delay of 0.1 s was used throughout, and data was
collected in centroid mode. A 1μl aliquot of filtered urine was injected onto a
2.1x100mm, 1.7μm Acquity UPLC BEH C18 column (Waters Corporation) held at 40°C.
Retained small molecules were eluted via a linear gradient of 98% A for 2 min, 2–50% B
from 2–11 min, 50–98% B over 12-12.49 min, returning to 98% A at 12.5 min and
remaining there until completion of the run at 15 minutes at an eluent flow rate of 0.25
ml/min; where A = 0.1% formic acid and B = 0.1% formic acid in acetonitrile. T he mass
spectrometric data was collected in full scan mode from m/z 80 to 1000 from 0.8 to 15
minutes. Urine samples were run in duplicate and analyzed using MeDDL using spectra
from 0.8-12 minutes. For ms/ms data, random urine samples were run using data
dependent acquisition with multiple voltages applied. Standards were purchased from
Sigma-Aldrich (St. Louis, MO) and run at 1 mg/ml (1ug injection) under the same LC-MS
conditions as the samples to validate retention times and ms/ms spectra. Sample
analysis for determination of differential metabolites was performed using the MeDDL
tool which is described below.
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Algorithms And Implementations
The overall goal of the MeDDL system is to facilitate the analysis of LC-MS
experimental results. With this goal in mind, the system is structured to provide a
global view of experimental results so a user can quickly identify samples exhibiting
interesting or unusual patterns of behavior while still having the option to probe these
samples at ever finer levels of detail. MeDDL accomplishes this by allowing the user to
search for relationships between subsets of subjects at selected times or treatment
levels. The user may ask for subsets which exhibit specific levels of change in the
behavior of the response. The user may restrict the fold-change to positive, negative or
combined levels of changes. For example, the user can seek all peaks that exhibited a 5
fold positive change between the control subjects and treated subjects at 24 or 48
hours. In addition, MeDDL also allows the user to perform detailed statistical analysis
including ANOVA (1-way, 2-way and N-way) among the selected subject groups. The
user can optionally perform multiple pairwise comparison tests among the means of
groups to determine whether or not all differences- among group means satisfy a user
defined level of significance. A Bonferroni correction is applied to compensate for the
tendency to incorrectly find a single pairwise significant difference among multiple
comparisons.
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The MeDDL system is composed of two major subsystems: peak analysis and
visualization. Peak analysis encompasses several subsidiary tasks including peak
extraction, peak registration and extraction of registered peaks sets. The visualization
system takes the information provided by the peak analysis subsystem and combines it
with information describing the overall experiment to allow the user to explore the
results from the perspective of the experimental parameters.

Peak Analysis Subsystem
In this section, we present a brief overview of the algorithms that comprise the
peak analysis subsystem. As shown in Figure 4 these algorithms include peak extraction,
peak registration and peak matching. Each algorithm is described below.
The peak extraction algorithm is composed of two phases. The first phase is
designed to form temporal clusters required for chromatographic time alignment and
the second phase partitions clusters into individual peaks. A full experiment consists of
hundreds of files from different LC-MS sample runs, each of which is identified by
subject, treatment, time, and optionally replication indices. A single LC-MS sample is
composed of a set of n measurement points P = [ pi | i = 1, 2, 3, … n ] of the form:
pi = (Mi,Li, Ii) with components of mass (Mi), scan number (Li) and intensity value (Ii).
Each scan (Li) also has a corresponding retention time (Ti). Extracted peaks are temporal
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Figure 4. Schematic overview of the peak analysis subsystem. (A) Sample peak cluster
extraction. (B) Sample peak cluster partition. (C) Preliminary peak matching for
registration. (D) Matched Peaks. pi,j = <Mi,j, Ti,j, Ii,j> – apex point of extract peak with
mass (Mi,j), register time (Ti,j) and intensity (Ii,j). The behavior of each row is summarized
by the average mass (Mavg,i), average registered time (Tavg,i), average intensity (Imax,i) and
a count of the number of peaks detected (Ni) (from Grigsby et.al. 2010).
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sequences of similar mass coordinates across multiple scans. A simple example of the
algorithm for forming peak clusters is shown in Figure 4A.
The peak extraction process is initialized by selecting a reference point (Ma, La, Ia)
with a large intensity which will become the apex of the resultant peak bounded by a
narrow mass band. The width of the mass band is set by a mass uncertainty parameter
(Δm) specified by the user. Within this mass-band, points are assembled into cluster
sequences in both temporal directions from the initial reference point, accepting only
one point per scan. A resultant cluster may grow to lengths spanning many peaks.
The next step, partitioning the cluster into individual peaks, is a difficult design
problem, because it must instantiate a peak definition that separates the significant
peaks from the noisy and uninteresting ones. Often, partitioning a cluster visually can
be difficult, so some ambiguous results are unavoidable. In other words, if it is difficult
to resolve peaks visually, it is difficult to automate. In Figure 4B there are many small,
jagged, noisy peaks and three or four prominent peaks. The decision to extract 3 or 4
peaks is determined by adjusting a user-accessible control parameter. In this example, a
closing operator from mathematical morphology [106] has been employed to filter out
unwanted peaks, including the fourth obvious candidate. The horizontal fill-in lines are
determined by the size of the structuring element used by the morphological operators
to probe the cluster’s structure.
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Peak Registration
Peak registration uses only mass and retention time coordinates (M a,Ta) of the
peak apices to achieve the significant data reduction required to work efficiently across
many LC-MS samples. Peak registration primarily involves temporal alignment of peaks,
although for some instruments the alignment of mass measurements is also required.
Initially, one of the images is selected as the reference image and all others are
transformed to match it. As illustrated in Figure 4C, this transformation is accomplished
by bracketing each peak with a maximum shift window (Δm, Δt) and identifying matching
pairs of peaks. Ideally, these are one-to-one unique matches, meaning each peak has
only one unique candidate match. A larger set of candidate matched peaks can be
defined by relaxing the criteria so that only the peak in either the reference image or
alignment images has a unique matching peak. The set of matched peaks is then used to
compute a polynomial transformation that maps retention times of images relative to
the reference image. The order of the polynomial is determined by the user (Eq. 1).
Eq. 1
Should the need arise to make adjustments to mass coordinates (Eq. 2); the set would
be used to compute a bivariate alignment polynomial.
Eq. 2a
Eq. 2b
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Peak Matching
The set of matching pairs of peaks is used to initialize a matrix of matched peaks
(Figure 4D). Each column represents one image and each row contains a set of
registered peaks. The peak coordinates (Ma, Ta) are averaged over non-empty images in
each row (Mavg,Tavg), producing a synthetic reference image so that the original
reference image is no longer required. A number of cycles of the matching algorithm
are then used to fill in existing rows and to extend the number of rows by seeding the
reference image with peaks from the pool of unused peaks. The coordinates of the seed
peaks are used as initial values for (Mavg,Tavg). Each iteration of the matching algorithm
produces new alignment polynomials by pairing image peak coordinates with the
evolving row averages. A peak matches the row average if its coordinates fall within a
(Δm, Δt) box centered on the row average, where Δt is much smaller than the Δm used for
pre-alignment matching pairs. The final matching step, which attempts to fill in any
empty slots in the matching matrix, is accomplished by selecting the raw data point with
the maximum intensity in the (Δm, Δt) acceptance box as a peak substitute.

Visualization System
The visualization system is based on the MVC (model-view-controller) software
architecture pattern [107]. The model is composed of a series of relational data tables
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that include the registered match peak table (Figure 4D), the experimental descriptor
table, cluster-peak data tables and raw sample data tables. The user interacts with the
model via a graphical interface that supports mouse and keyboard input. The
communication between the controller and the model is implemented using callback
mechanisms defined in the Matlab programming language. When the user triggers a
callback event, the controller notifies the model of the user’s action and then possibly
alters the state of the model. The view may automatically be invoked by the controller
to update some subset of displays as a result of a change in the state of the model or
the view may query the model to generate a display based on a user request.
The user interaction with the model is organized into a collection of filters that
allow the user structured access to the various components of the data model (Figure
5). These filters are divided into logical categories: data, statistical, chemical, and
experimental. The data filters allow access to subsets of data that are restricted by
mass, retention time or intensity. The statistical filters allow the user to locate
statistically significant patterns of behavior across the entire set of registered peaks.
Chemical filters allow the user to remove certain peaks from the analysis based on
chemical properties. For example, isotopic peaks or adducts can be automatically
filtered to simplify analysis. Finally, experiment level filters allow the user to select

52

Figure 5. Visualization system overview (from Grigsby et.al. 2010).
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items related to the biological experiment such as treatments levels or longitudinal
studies for analysis.
The filtered data is visualized through a variety of displays. The displays allow a
multifaceted view of the data. Figure 6 demonstrates one series of filter-display
interactions possible using the visualization system. In this example, the main display
opens with a view of all registered peaks stored in a summary table along with a heatmap. Each point in the heat-map represents the location of a registered set of matched
peaks. The position of the point in the heat-map denotes the peak-set’s average mass
and average retention time. These correspond to the values of (M avg, Tavg) shown in
Figure 4D. The brightness of the point is determined by the value of the most intense
peak in the registered set (Imax in Figure 4D). As shown in Figure 6, the user can apply a
data filter to identify a smaller set of registered peaks for analysis and then alter the
view to show line plots summarizing the behavior of several registered peaks. The user
can select a single registered peak, plot the behavior of all samples as a function of the
experimental parameters (treatment vs time) and select a specific sample for further
analysis. Additionally, the user can explore the raw data in a 3D scatter plot with the
ability to zoom-in and zoom-out in any specified spectral region.
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Figure 6. Example MVC (model-view-controller) interaction (from Grigsby et.al. 2010).
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Results and Discussion
To illustrate the utility and power of MeDDL in the visualization of large, multigroup experiments, we analyzed data from an LC-MS effort for profiling low level kidney
biomarkers in the F344 rat model. Importation of the raw QToF MS data files and
subsequent analysis of the aligned and registered peak database by MeDDL identified
numerous metabolic changes in the urine of the animals after D-Serine treatment
compared to control animals. Registration and processing of the D-serine exposure data
(n=208) utilizing peak inclusion criteria requiring each m/z at a given retention time be
present in a minimum of 5% of all samples was accomplished in 122 minutes. A smaller
sample set of n=20 was similarly registered and processed in 12 minutes to establish
scalability, with all analysis performed utilizing a dual core 2.53GHz CPU with 6 GB of
RAM. This alignment and registration encompassed all detectable peaks, with absolute
intensity values as low as 30 being registered (background level previously established
by our group for the QToF Micro).
To verify the accuracy of the registration and analysis algorithms, a spiked study
of control F344 rat urine was performed (Figure 7A) using a purchased metabolite test
mixture of five known compounds (Waters Corporation Metabolomic Test Mix). An
artificial dose response was generated as shown below (Table 4) and examination of
nortryptyline (m/z 264.1752), the highest intensity standard in this set, via Masslynx
(Waters Corporation) generated the response illustrated in Figure 7B (below). Following
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A
m/z 264
TIC

Metabolite Stds
800
700

Mass (264.1792) Retention Time(9.8478) Peak No(1285)
700

B

Intensity 264 m/z
(Replicate 1)

600

Intensity 264 m/z
(Replicate 2)

500
Maximum Intensity

600
500
400
300

C

400

300

200

200

100

100
0

0

0 Hr

24 Hr

48 Hr

72 Hr

96 Hr

0 hrs

24 hrs

48 hrs
Sample Time

72 hrs

96 hrs

D

Figure 7. A – Spectra from spiked study of control F344 rat urine showing presence of
nortryptyline in spiked urine, TIC of spiked urine sample, and TIC of neat test mixture
utilized in spike. B – Nortryptyline dose response obtained via Masslynx (Waters Corp.).
C - Nortryptyline dose response obtained via MeDDL following alignment and
registration. D – Selection of nortryptyline via MeDDL as showing >5-fold change in time
versus treatment (from Grigsby et.al. 2010).
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0 Hr
24 Hr
48 Hr
72 Hr
96 Hr

Theophylline
0 pg
750 pg
3.75 ng
375 pg
750 pg

Caffeine
0 pg
750 pg
3.75 ng
375 pg
750 pg

Hippuric Acid
0 pg
750 pg
3.75 ng
375 pg
750 pg

4-Nitrobenzoic acid
0 pg
375 pg
1.88 ng
188 pg
375 pg

Nortryptyline
0 pg
281 pg
1.41 ng
141 pg
281 pg

Table 4. List of spiked standards (Waters Corporation Metabolite Test Mix) in F344
control urine utilized in software validation study generating a synthetic dose response
(from Grigsby et.al. 2010).
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processing by MeDDL, nortryptyline was registered by the software generating an
identical response curve to that manually determined in the vendor supplied instrument
control software (Figure 7C). Analysis of the spiked data utilizing the previously
described fold change filter for all masses showing a 5-fold change across time for a
given dose showed inclusion of nortryptyline (Figure 7D). Accuracy in both the ability of
the software to perform correlations as well as in peak registration can be
demonstrated through correlation of adducts and isotopes in the aligned peak database,
which also allows for their easy visualization and elimination as candidate biomarkers.
As described, twenty separate groups (4 doses x 5 time points) totaling 208
samples were analyzed. Following alignment and registration of the D-serine exposure
data, more than 4000 isotopic peaks were originally registered and matched prior to
automated de-isotoping via MeDDL. During this process the isotopes were identified
after peak matching was complete. The location (Mavg,Tavg) of each synthetic peak was
used to initiate a search for mono-isotopic peaks. For a given peak, a search was
conducted to located mono-isotopic peaks by looking for a peaks at location
(Mavg + 1,Tavg) (Mavg + 2,Tavg) and (Mavg + 3,Tavg). A match was found if a peak was located
within the region defined by (Mavg + 1 ±Mε,Tavg±Tε) where Mε and Tε is a user specified
limit on mass and retention time variation between isotopic peaks. Once a potential
isotope is identified, the intensity of the actual extracted peaks (main peak and isotopic
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peak) in each image is compared to verify that the isotopic peak has a decreasing level
of intensity. If all peaks in the set and their corresponding isotopic peaks satisfy this
requirement, the isotopic peaks are tagged and can be hidden / removed by the user. A
similar process is used to locate doubly and triply charge isotopic peaks and tag them for
removal.
One of the novel aspects of the MeDDL peak alignment process is the use of a
two stage process that begins with a rough peak match where only a few isolated peaks
are identified between a reference image and each unregistered image. These initial
peaks are used to compute a polynomial transformation between the reference image
and the unregistered image producing a rough alignment. This is essentially a global
process that handles systematic misalignment between images. In the peak matching
phase, alignments are refined through a process similar to relaxation labeling [108, 109].
After the rough alignment, a synthetic image is created by taking each image in turn and
using every peak in the image as the center of a peak acceptance region. Any peak in
any other image captured within the acceptance region is matched to this peak. The
average mass and retention time (Mavg,Tavg) across the set of peaks is computed as
(Mavg,Tavg). Initially, the acceptance region is very small so peaks that were not wellaligned by the polynomial function will not be matched. The relaxation process slowly
opens the size of the acceptance region to attempt to draw in one peak from each
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image. Each time a new peak is captured within the acceptance region, the average
(Mavg,Tavg) is recalculated. Thus, the acceptance region gradually shifts and coalesces to
maximize the number of matched peaks across all images at the final value of
(Mavg,Tavg). This combination of global alignment / local refinement allows the matching
to respond to both systematic misalignments as well outliers that appear as random
variations within individual images. Additionally, although MeDDL accurately aligned all
data generated by our laboratory, the retention time variation observed with the
Waters Corp. Acquity UPLC was minimal (<0.25 min). As such, alignment was achieved
through the use of a 2nd order polynomial and our two stage peak alignment process.
During development, our group evaluated use of higher order functions; however, we
deemed it unnecessary for our use. This can be easily modified to be a user editable
feature through the software interface if necessary for other chromatography systems.
During the analysis of the exposure data, two of the primary tools included in the
MeDDL platform were utilized by our group, principal component analysis [110] (PCA)
and a novel fold change filter. The design of the fold change filter analysis is based on a
multilevel statistical model that views the behavioral response (intensity) of each
synthetic peak as a normally distributed random with the added assumption that the
behavior of peaks within individual images is correlated. Based on this underlying
statistical model the system is designed to handle longitudinal data sets consisting of
61

subjects exposed to multiple levels of treatments. The statistical models are designed
to allow the user to perform statistical tests for significant differences between
treatment levels, significant differences between treatment time points, or significant
differences between any combination of treatment levels or time points. In future
applications, if other analysis tools become required, MeDDL is easily expandable
through its use of the MVC software architecture previously described. This software
architecture allows a programmer to extend the functionality of the system as follows
(1) add a new choice to any pull-down menu in system menu, (2) install a new callback
for the menu item that invokes a user defined function, and (3) create a new user
function (userFunction.m). The user code added to userFunction.m has full access to all
Matlab libraries (e.g. image processing, signal processing, pattern recognition, statistics,
etc.) and full access to the summary data describing the matched peaks, the full
description of every peak in a matched set and the raw data for every image. This
allows a programmer / user to add new functionality to the system without altering the
existing functionality.
PCA was performed for all groups of study animals and is shown in Figure 8. The
PCA plot demonstrates clear separation between sample dosage and time groups with
the majority of metabolomic changes in urine observed at 24, 48 and 72 hours post
treatment with 500 mg/kg D-Serine. The number of peaks that undergo at least a 2-fold
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Figure 8. A - Principal component analysis of LC/MS data for all experimental animal
groups of the study. Legend is on the right of the figure. B - Principal component analysis
of LC/MS data for 0, 5, 20 and 500 mg/kg doses at 24 hours only (from Grigsby et.al.
2010).
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change is 19 times higher for the 500 mg/kg dose than the 5 mg/kg dose, with the
changes literally disappearing at 96 hours, most likely indicating kidney recovery.
At 24 hours post-dosing for the 500 mg/kg group, as many as 426 peaks show a
greater than 2-fold change with the peak intensity cut-off set to a minimum of 100.
Although the 2-fold increase was established based on our goals of identifying
differential yet detectable metabolite biomarker profiles, the fold change filter
incorporates detailed statistical analysis including ANOVA (1-way, 2-way and N-way)
among the selected subject groups. The user can optionally perform multiple pairwise
comparison tests among the means of groups to determine whether or not all
differences among group means satisfy a user defined level of significance. A Bonferroni
correction is applied to compensate for the tendency to incorrectly find a single pairwise
significant difference among multiple comparisons. Further, five metabolite peaks
exceeded 100-fold change with the same intensity threshold. It is worthy to note that a
number of peaks exhibit a statistically significant change while their intensities are
relatively low, with most of these peaks demonstrating negative changes in our analysis.
Examples of negative and positive changes are shown in Figure 9. We have excluded
isotopic peaks in our data analysis; however, some percentage of differentiated peaks
can be attributed to adduct acquisition by metabolites as well as water loss. Thus the
difference of 18 mass units between peaks 1569 and 1598; 952 and 246; 1642 and 1532;
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Figure 9. Examples of selected peak plots of negative (A) and positive (B) changes after
500 mg/kg D-Serine exposure (from Grigsby et.al. 2010).
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1697 and 1664; and 3277 and 42 strongly suggest a water loss with each set of ions
eluting from the column concurrently.
Preliminary metabolite identification was performed, with a list of potential
metabolites shown in Table 5. Purchased metabolite standards were run under the
same LC conditions followed by MS/MS as selected samples. Matching retention times
and MS/MS fragmentation data generally indicate the conclusive identification of a
metabolite, which has been demonstrated in a candidate biomarker identified in this
study, 3-indolylacetic acid. The MS/MS spectrum of 3-indolylacetic acid along with a
spectrum from rat urine samples is shown in Figure 10. This figure also demonstrates
the ability of the MeDDL to automate spectral normalization. In MeDDL, normalization
begins by computing the mean (m1, m2, m3,…) and standard deviation (s1, s2,s3, …) of the
values of all subjects in each treatment group at the first time point. The peak intensity
value ps(t) for each subject s in group j at time t is then normalized as: (pi(t) - mj) / sj.
This effectively shifts all the plots so the mean value of the first time point in each
treatment group is zero (see Figure 10C).

66

m/z
521.2412
523.2543
491.2421
501.2701
714.1853
611.3051
609.2873
567.2799
613.3242
383.1925
779.352
290.1256
655.3292
435.159
589.3217
479.2284
701.3726
326.1946
553.2582
633.3461
212.1025
330.0621
533.1005
511.2622
290.1258

Retention Time
9.071536
10.508634
7.5071826
9.916751
1.6265737
10.67593
9.332852
10.59735
11.733243
4.111277
1.4149536
1.469668
10.74838
10.100951
10.138795
10.405753
11.777291
9.491132
4.0478706
10.232473
1.1299926
2.3208911
4.628623
4.253147
1.7111521

Treatment x Time pvalue
3.31E-05
8.04E-05
1.44E-04
1.74E-04
2.22E-04
2.60E-04
5.72E-04
7.30E-04
9.17E-04
0.00169446
0.00176583
0.00190476
0.00203854
0.00356158
0.00407047
0.0055822
0.00567922
0.00787954
0.01769215
0.01919617
0.02197477
0.02478929
0.04081653
0.04097449
0.04116634

Table 5. List of potential metabolites (shown as m/z) identified in urine of rats after 500
mg/kg D-Serine exposure at 24 and 48 hours after the exposure. Fold change filter set
at 10 fold and higher (from Grigsby et.al. 2010).
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Figure 10. Identification of a selected metabolite. Retention times and MS/MS
fragmentation of 3-Indolylacetic acid is shown for standards along with corresponding
ms/ms from D-Serine urine samples in A. Not normalized (B) and normalized (C) plots
show changes for 3-Indolylacetic acid throughout the course of D-Serine study (from
Grigsby et.al. 2010).
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Conclusions
The data clearly demonstrate dramatic changes in the urinary metabolic profile
in response to the kidney toxicant, D-Serine. A list of potential metabolites
corresponding to masses identified in urine of rats is presented. D-Serine metabolomic
profiling demonstrates that most changes occur between 24-72 hours. The most
dramatic changes occur at the 24-hour time point after exposure to 500 mg/kg D-Serine.
The data suggests that near-normal kidney function resumes at 96 hours.
Although the ability to visualize the experiment at all levels may constitute the
authors’ ideal for biomarker discovery and differential metabolite analysis, we feel it
adds considerably to this effort by allowing the user to differentiate metabolite profiles
in a large time-dose study while maintaining the ability to focus on individual
metabolites and spectra for subsequent identification. Additionally, although the tool
performed quite well for LC/MS dose response study analysis, some early limitations
were identified in the prototype version of the tool, principally the ability analyze data
obtained via GC/MS. GC/MS data presents a specific set of challenges, primarily due to
differences in the ionization technique utilized. To address these challenges as well as
implementing several marked improvements to the tool, significant changes to the
prototype software were completed, as described below.
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CHAPTER 4. GC/MS FUNCTIONALITY AND EXPANDED TOOLSET

Overview
As stated in Chapter 1, a growing body of discoveries in molecular signatures has
revealed that volatile organic compounds (VOCs), the small molecules associated with
an individual's odor and breath, can be monitored to reveal the identity and presence of
a unique individual, as well their overall physiological status. Given specific analysis
requirements for differential molecular profiling via gas chromatography/mass
spectrometry, our group has expanded on the prototype Metabolite Differentiation and
Discovery Lab (MeDDL) tool to allow for processing of VOC data [89]. Preliminary
analysis via the MeDDL toolset generally identifies a moderately large number of
differential, registered peaks, which, depending on filtering and comparison parameters
could be in the range 50-100 peaks separating the conditions of interest. This initial,
down-selected subset of peaks is typically too large for incorporation into a portable,
electronic nose based system in addition to including VOCs that are not amenable to
classification; consequently, it is also important to identify an optimal subset of these
peaks to increase classification accuracy and to decrease the cost of the final system. In
this chapter, we will discuss an approach to how this differential peak subset and their
corresponding intensities are used as features for classification.
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As the first illustration of our approach to these studies, we present the below
urine based VOC comparison of the two parental strains of the BXD mouse model [111],
C57 and DBA. For this comparison, we demonstrate the expanded MeDDL functionality,
to include machine learning tools via a classifier similar to a K-nearest neighbor (KNN).
This modified KNN classifier is used in conjunction with a genetic algorithm (GA) that
simultaneously optimizes the classifier and subset of features. The GA utilizes receiver
operating characteristic (ROC) curves to produce classifiers having maximal area under
their ROC curve. Using this approach, experimental results shown below on over a
dozen recognition problems show many examples of classifiers and feature sets that
produce perfect ROC curves.

Data Filtering
Following the spectral registration and alignment previously described [100], the
data was analyzed using several of the principal analytical methodologies included in
MeDDL: unsupervised clustering via principal component analysis [110]; differential
down selection of peaks through combination of a set of logical filters; and utilization of
machine learning based tools for significant VOC “feature” identification.
MeDDL was originally created for the analysis of LC/MS data. The ionization
techniques generally employed for LC/MS are termed “soft” and impart low energy to
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eluting ions, resulting in fairly simple mass spectra: often comprised of just the ionized
analyte, or “parent” ion. Modifications to the original implementation of MeDDL were
required to aid in the analysis of the more complex mass spectra in GC/MS resulting
from the “hard ionization” induced by the electron impact (EI) fragmentation process in
the mass spectrometer’s ion source. A reductionist approach for this analysis was
required for the efficient determination of changes observed between sample groups.
To address this issue, we created a supplementary time-binning filter allowing the
analyst to specify both a time window and lower bound threshold of peak intensities.
The comparison then proceeds as follows: an averaged, composite image of each userdefined comparative group is generated (i.e. the surface obtained from samples
comprising each comparative group); the most intense peak from all groups is evaluated
across all aligned images using a 0.1 minute window and 100,000 absolute (total ion
count) threshold; once the comparison is completed, this “time slice” based upon the
peak apex ± ½ of the specified time window is removed from further analysis and the
next most intense set of peaks are compared. An additional filter applied in the
differential analysis of groups in this study included a fold change filter limiting results to
only those peaks which demonstrated at least 2 fold or greater change in intensity
between strains. It must be noted that although the MeDDL tool contains a wide variety
of implemented statistical filters for feature down-selection, we limited their use to only
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the 2 filters listed to allow for optimal feature selection by the classifier. Once both of
these filters were applied to the grouped, global data set, a Boolean "AND" was added
to the resulting filtered peak sets to identify the logical intersection, an approach similar
to that used in generation of a Venn diagram. These reduced data sets were then used
for further classification described below.

Classification
The filtered, numerical data sets, or feature vectors, produced by the
preprocessing described in the previous section must be used to perform classification
on unknown samples for optimal results. However, performing classification with these
features still presents several problems. First, the filtered features include noisy,
irrelevant features, despite the preprocessing steps taken to identify features that have
both intra-class similarity and inter-class dissimilarity. Second, the set of filtered
features include those that are highly correlated and therefore are redundant. These
two observations suggest the classification system should produce a classifier, but
should also down select the incoming feature set to a small set of cooperative features
that are amenable to classification.
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Modified K-Nearest Neighbor Classifier
The basic KNN is a two-class classifier that is often used in situations where the
data distributions are generally unknown [112]. KNN training is performed by using all
samples of the training data as labeled prototypes. Unknown samples are classified by
comparing the distance of the unknown sample to the k nearest prototypes, where k is a
small user-defined integer (e.g., 3). In binary classification (i.e., -two class classification),
choosing an odd value for k avoids a potential tie vote. The method of computing
distance with N-dimensional data is commonly done in two different ways: Euclidean
distance and L1 norm, or Manhattan/Minkowski distance formula using p = 2. This work
uses Euclidean distance, but the L1 norm appeared to provide similar results. The three
nearest prototypes then vote on the unknown’s class label. Figure 11 illustrates this
process in two dimensions. In this sample, the training data contains 5 samples, which
includes 3 positive samples and 2 negative samples. The three closest samples to the
unknown are S1, S3, and S4, with the majority those samples being positives;
consequently, the unknown would be labeled as positive.
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Figure 11. Example data and plot of data (from Grigsby et.al. 2012).
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One unique objective of this work was to develop a classifier that has one or
more parameters that control the classifier’s behavior. For example, it may be
important to correctly classify positives, with an increased tolerance for false alarms.
Conversely, it may be deemed acceptable to miss a couple positives, if the increased
number of false alarms is kept small. The k parameter in the KNN classifier does not
provide such a parameter. k simply denotes the number of voters and does not provide
a way to increase/decrease the sensitivity toward the class boundaries. Further, the
number of prototypes is typically quite small in biological studies and therefore
modulating the number of voters would have limited utility.
For an appropriately configurable classifier, a ROC curve visually illustrates the
possible tradeoffs between the rates of true positives and false positives. Figures 12a
and 12b illustrate a typical ROC curve and the perfect ROC curve. Figure 12a depicts the
tradeoffs of a hypothetical classifier. The figure shows that the classifier has a
parameter that can allow it to obtain a 0.75 true positive rate, while simultaneously
having a false alarm rate of 0.25. Should the operational situation require 0.9 rate of
recognizing true positives, the rate of false alarms would reach a predicted level of
approximately 0.75. ROC curves are monotonically increasing. The perfect classifier
would obtain a rate of 1.0 for positives with a false alarm rate of 0.0. This perfect ROC
curve is shown in Figure 12b.
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12a

12b

Figure 12. ROC Curves. Figure 2a shows a typical ROC curve. Figure 2b shows the
perfect ROC curve (from Grigsby et.al. 2012).
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To provide for an adjustable parameter, the KNN’s decision rule is modified (Figure 3).
Whereas, the basic KNN’s decision rule is to count the votes to the nearest k prototypes,
the modified decision rule uses the distance value to influence its decision. This is
approach assumes that being closer to a prototype indicates that it is more likely to be
of that category. The definition for the modified KNN decision rule is as follows, where T
is the configurable parameter and k is an integer > 0. The classification rule takes the
ratio between the total distances to the closest positive prototypes and the closest
negative prototypes. If the unknown happens to be a positive, it is expected that
posDistance would be small and negDistance would be large, producing a small value for
ratio. By adjusting T to a small value, the criteria for declaring “positive” becomes more
stringent, in that the unknown’s distance from the positives must be quite small while
simultaneously its distance from the negatives must be relatively large. Conversely,
setting T to a large value allows more samples to be classified as positives. In the
extreme case, T = infinity, all unknown samples will be classified as positives.
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Figure 13. Modified KNN pseudocode (from Grigsby et.al. 2012).
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Learning Algorithm for Feature Selection
After preprocessing, the set of filtered features is sent to the classification
system. As mentioned above, the potential exists for reducing this set to an even
smaller number. Ideally, this reduction would produce a less costly system and produce
a subset of features that are more effective than using the entire set as a whole. The
ideal subset would contain features with general properties such as: mutual
independence, inter-class dissimilarity, and intra-class similarity. Rather than applying
more filters to achieve this, our approach is to use the modified KNN classifier to assess
the quality of a feature subset; where good subsets will provide good classification and
poor subsets will not be very accurate.
The process of selecting a subset from a large set uses a sequence of 0’s and 1’s
to represent the subset. Here the bit positions containing a 1 or 0 indicate features to
be included or excluded. Figure 14 shows a diagram illustrating how one bitstring is
used to down-select the features and how that down-selection affects the resulting data
set that is fed to the KNN learning algorithm. In this example, the bitstring happens to
have three on-bits located at positions 2, 4, and 5, indicating that only features 2, 4, and
5 are used and features 1 and 3 are ignored. The down-selected data is then used to
form the modified KNN.
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Figure 14. Reduction of Training Data. The topmost figure shows the entire set of data.
The middle figure shows one bitstring produced by the GA. The bottommost figure
shows the training data without the excluded features (from Grigsby et.al. 2012).
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A GA is a natural learning algorithm to apply to this problem [113, 114] since it
operates on a bitstring. The reader is referred to the text by Goldberg [115] for a more
complete treatment of GAs. For our purposes, it suffices to say that the GA is a method
for optimizing a sequence of 0’s and 1’s. In order to achieve this, the GA requires a
method for evaluating the quality of the sequence. By assigning a numeric score to a
sequence, and many other sequences, the GA navigates the search space to find
sequences that are better than the ones it is currently is examining.
Leave-one-out (LOO) cross validation [112, 116] is a common method for
estimating the quality of a classifier using only training data. LOO iterates over all the
training samples, where each sample is temporarily removed from the training set. This
smaller set is then used to train the classifier, which is then applied to the sample that
was held out. Ideally, the classifier will correctly classify the sample. By repeating this
process over all training samples, it is possible to assess the generality of the learning
technique. If the LOO algorithm shows solid performance over a large percentage of the
samples, it can be assumed that the learning technique generalizes to truly unknown
samples.
On each iteration of the LOO algorithm, the bitstring in question ultimately
results in a KNN that is used to classify the sample temporarily removed. Instead of
classifying the sample, the ratio between posDistance and negDistance is recorded. The
82

set of ratios can be used to create a ROC curve that predicts the final system’s ROC
curve, where the final system refers to the modified KNN that is obtained by using all of
the training data. The area under the predicted ROC curve is used as the bitstring’s
evaluation score. Naturally, a score of 1 corresponds to a perfect ROC curve, which
indicates that the feature set forms an effective KNN classifier.

Materials / Methods for Machine Learning
Animal use in this study was conducted in accordance with the principles stated
in the Guide for the Care and Use of Laboratory Animals, National Research Council,
1996, and the Animal Welfare Act of 1966, as amended. BXD mice parental strains (DBA
and C57) utilized for this study were singly housed in metabolic cages which are
approximately 9 cm in diameter and urine and feces were separated and isolated.
Individual mouse urine samples were collected using 1 mL disposable transfer pipettes
(Thermo Fisher Scientific) and placed in 2 mL Eppendorf Snap-Cap Microcentrifuge SafeLock tubes. The urine was then stored frozen at -80°C and thawed on ice prior to
analysis. For the BXD VOC baseline set described, 170 individual samples representing
the two parental strains (C57 N = 81, DBA N = 89), and six additional test samples (C57 N
= 3, DBA N = 3) were processed by aliquoting 200 uL of urine into a 10 ml crimp-top
headspace vial (National Scientific). The vials were immediately crimped with Red
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PTFE/white silicone crimp seals (Fisher). The bench-top GC/MS system utilized for
sample analysis was a Thermo Fisher Trace GC Ultra gas chromatograph interfaced to a
Thermo Triplus autosampler configured for automated SPME headspace sampling and
in-line with a Thermo DSQII single quadrupole mass spectrometer. Collection of organic
volatiles from the urine was accomplished using a 2cm CAR/DVB/PDMS solid phase
micro extraction fiber (SPME), Supelco supplier, inserted by the Triplus autosampler into
the head-space of the sample vials. The headspace samples were incubated at 60°C for
15 minutes, followed by extraction at 60°C for 30 minutes and automated direct
injection. Volatiles gathered by the SPME fiber were analyzed through desorption of the
fiber by heating to elevated temperature and separation with a Restek Stabilwax 30m,
0.25mm ID column. Helium was used as the carrier gas at a flow-rate of 1.5 ml/min. A
narrow bore SPME injector liner (0.75 mm I.D.) was used (Thermo). The following
conditions were utilized for sample analysis: desorption for 2 min via a PTV injector held
at 230°C; oven temperature program 50°C (4 min); 5°C/min to 230°C; hold 30 minutes
giving a total run time of 70 minutes. The DSQII MS transfer line was held at 230°C and
the instrument was operated in positive scan mode from 41 to 400 amu. The raw data
was collected in centroid mode and the resulting chromatograms and mass spectra (raw
files) were then converted to CDF format and subsequently analyzed through MeDDL.
Due to the fact that SPME extraction is a competitive process leading to mutual
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displacement from the adsorption sites between different analytes or analytes and
matrix constituents, the results of this study as described report data semiquantitatively based on relative peak heights.

Machine Learning Results
A total of 170 BXD parental urine samples (DBA and C57 “teaching set”) were
collected and analyzed over a four month period with the six unregistered “unknown”,
test samples utilized below acquired over 12 months later. Following GC/MS analysis,
CDF conversion, and MeDDL registration, the samples in the “teaching set” were filtered
for a 2-fold change and time binned (0.1 min window, 100K absolute threshold
minimum cutoff). The filter results are shown in Table 1, with peakset 1 comprising all
registered peaks, peakset 2 comprising time binning, peakset 3 comprising fold change,
and peakset 4 the resultant intersection of the two applied filters. This subset of 52 VOC
features, or peaks, were first screen by PCA (Figure 15) to demonstrate group
separation prior to analysis by the hybrid GA classifier. Principal component analysis is a
mathematical procedure that uses an orthogonal transformation to convert a set of
observations of possibly correlated variables into a set of values of linearly uncorrelated
variables called principal components. This technique is often difficult in usage to
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PkSet 1
PkSet 2
PkSet 3
PkSet 4

Subset
All Peaks
Time Binning
Fold Change
PkSet 2 AND PkSet 3

Parameter
Delta T: 0.1 Min Int: 1000000
2
Boolean AND

Size
2845
293
500
52

Table 6. BXD parental strain peak registration and peakset (PkSet) filter results (from
Grigsby et.al. 2012).
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Figure 15. PCA of C57 and DBA filtered intersect (peakset 4) results (from Grigsby et.al.
2012).
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identify the individual subset of features responsible for group separation, but is quite
useful as a screening technique as in Figure 15.
MeDDL offers users the ability to utilize several different types of classification
methods and separately store the resulting output for classification of additional,
unregistered unknowns. These methods use a combination of pre-coded Matlab
classifiers, Waikato Environment for Knowledge Analysis (WEKA) classifiers, and the
novel, in-house developed hybrid GA classifier, implemented in Java and Matlab,
described in this study (Figure 16). The internal data classification allows users to teach
the classifiers from peak sets generated using the tool. The external data classification
is currently designed to process both CDF format files and comma separated value files
(.CSV). All classification methods support classifying intensities or ratios of intensities
though application of appropriate data filters.
In testing the hybrid GA for this study (Figure 17), setting k = 2, minimum
features = 4, and maximum features = 10 provided both perfect classification of C57
versus DBA for both the 170 teaching samples as well as the 6 “unknown” external
samples. Reverse classification (DBA versus C57) using these same settings resulted in 2
mis-classifications of the “unknowns” illustrating the need to optimize the GA settings
for each classifier result.
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Figure 16. MeDDL tool machine learning implementation and GA settings (from Grigsby
et.al. 2012).
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Figure 17. Hybrid GA results. Vertical line is user adjustable slider to determine T
threshold values (from Grigsby et.al. 2012).
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Results of the hybrid GA classifier were comprised of 10 VOC “features”, which is
the maximum features size allowed by the GA settings. An example of one of the
selected VOCs is shown in Figure 18. In an focused biomarker study, each resultant
peak would then be preliminarily identified through comparison to the National
Institute of Standards and Technologies (NIST) 08 database and Wiley libraries and
verified though expert, manual spectral analysis and comparison with purchased
standards.

GC/MS Functionality Conclusions
The MeDDL platform has been markedly improved from the original version,
with streamlined analysis of multi-group comparisons through the addition of a more
intuitive interface, the ability to dynamically alter group definitions and group
comparative displays, and the creation of definable, group comparative graphics. These
changes in combination with the addition of machine learning approaches greatly
enhance the capability of the tool and future applicability to studies requiring biomarker
discovery for sensor and diagnostics applications. In the following chapter, several
other examples of the universal utility of the tool in support of various GC/MS
differential profiling studies will be described.
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Figure 18. Boxplot of hybrid GA VOC feature output selected by classifier (from Grigsby
et.al. 2012).
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CHAPTER 5. GC/MS DATA PIPLELINE

Overview
To best demonstrate that the application of the comparative algorithms, logical
operators, and statistical filters implemented in the developed software tool allow for
the efficient analysis of GC/MS based VOC profiling studies, a variety of studies were
analyzed and presented below. Some of these studies in particular presented unique
data handling challenges and aided in identification of needed enhancements required
in future, "real-world" applications described in the following chapter. Analysis of these
separate data sets also help provide validation of implemented algorithms with
examples provided. Experimental examples of application of the volatile analysis
pipeline developed, illustrated in Figure 19, and described below include:
characterization of both human and murine urine as it ages, human markers of age and
ethnicity in axillary odors, and characterization of the binding between volatile ligands
and murine major urinary proteins (MUPs).
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Figure 19. GC/MS Data Pipeline Utilizing the Metabolite Differential and Discovery Lab
(MeDDL) Tool.
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GC/MS Experimental Example 1: Differential Binding Affinities Between Volatile Ligands
and Urinary Proteins Due to Genetic Variation in Mice
A collaborative study was completed using the MeDDL tool with scientists from
Monell Chemical Senses Center (Philadelphia, PA) to investigate the composition of
bound and unbound VOCs on the mouse major urinary proteins (MUPs) of various
inbred species. This effort was part of an investigation on the nature of murine volatile
and pheromone based signaling and is described in detail in Kwak, et. al., 2012 [117]. In
short, a comparison of the binding affinities in pooled male urine samples from three
different inbred mouse strains (B6, BALB/b and AKR) was completed by measuring the
release of volatile ligands before and after denaturation of the MUPs via SPME based
headspace concentration and GC/MS analysis. The sample set analyzed consisted of
pooled urine samples collected over a 10 day period, one from each of the individual
mice in the experiment (N = 8 B6, 7 AKR, and 6 BAL/b mice respectively). Raw spectral
data of both intact and denatured murine urine was supplied by Monell along with
associated metadata of the study group samples. A sampling of the raw spectral data
was first reviewed for chromatographic and spectral reproducibility across the major
urinary peaks, and then for instrumental absolute baseline and peak intensities to be
used for spectral registration and alignment. All data was then converted to netCDF
format and aligned/registered via the MeDDL tool, resulting in a total of 1895 peaks.
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Figure 20. Principal component analysis of the GC/MS data for the six different groups
(a) and for the intact and denatured groups (b) from Kwak et.al., 2012.
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Following registration and alignment, the GC/MS data were analyzed by PCA and the
fold change filter as described in Chapter 4. Screening for group separation via PCA,
shown in Figures 20a-b demonstrate clear separation between each of the six different
groups as well as between intact and denatured groups, indicating that both strain
difference and protein denaturation are important contributors to the unique volatile
profiles. To identify those peaks responsible for the separation observed via the PCA,
we used a combination time-binning (due to EI fragmentation), tests for fold-change
and statistical significance, and absolute intensity using the below parameter values.
We restricted the fold-change to only those time windows which demonstrated two fold
increased levels of change upon protein denaturation (positive change) within a
specified time slice of 0.1 minutes and an intensity threshold of 300,000 absolute
intensity (total ion count). A test for significance between all comparisons was also
completed using N-way ANOVA (P≤0.1), which included Bonferroni correction to
compensate for the tendency to incorrectly find a single pairwise significant difference
among multiple comparisons. Results obtained from the three strain specific pair-wise
comparisons of intact to denatured samples displayed the increased release in 49 peaks
induced by protein denaturation in AKR, 26 in B6, and 36 in BALB/b, respectively. Figure
21 illustrates the changes in the release of ligands upon denaturation.
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Figure 21. Changes in the release of ligands upon protein denaturation in the urine
samples derived from different mouse strains. The y axis indicates the absolute intensity
of the base peak ion in each ligand. I: intact urine; D: denatured urine. The degree of
release in each ligand was distinctive in each strain.
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GC/MS Experimental Example 2: Changes in Volatile Compounds of Mouse Urine as it
Ages: Their Interactions with Water and Urinary Proteins
A collaborative study was completed using the MeDDL tool with scientists from
Monell Chemical Senses Center (Philadelphia, PA) to investigate changes in the volatile
composition of mouse urine as it ages. This effort was part of an investigation on the
nature of murine volatile and pheromone based signaling and is described in detail in
Kwak, et. al., 2013 [118]. In short, the amount of water in an aqueous sample influences
releases of VOCs from the sample. As the sample dries, evaporations of water-soluble
VOCs accelerate, whereas the loss of water may render some VOCs to bind to solid
surfaces, preventing them from being released into the air. A number of studies
measured the loss of VOCs as male mouse urine aged. Some VOCs were removed
rapidly, whereas others were released slowly. However, the previous studies did not
clearly demonstrate whether the gradual releases of the VOCs were due to their binding
to MUPs and/or due to the loss of water as urine became dried. In addition to the roles
of water in the release of VOCs mentioned above, the loss of water in urine may alter
the structure of MUPs, losing their ability to retain volatile ligands. Here, we
investigated the effect of water loss on the releases of VOCs while mouse urine dried,
and determined whether the ligand-binding ability of MUPs in the dried urine remains
active. Using similar sample collection and GC/MS methodologies utilized in Kwak, et.
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al. 2012, a data set comprised of 24 chromatograms were generated from a pooled
collection of 4 - B6 male mice and 3 - B6 female mice acquired over several days by
analysis of 12 aliquots of each sex pool. These 24 aliquots (12 for male and 12 for
female) were separated into 6 condition groups, giving an N=3 per treatment.
Treatment groups consisted of "intact", "aged", "aged + water", and "aged + water +
GdmCl" with each treatment described in detail in Kwak, et. al., 2013. Raw spectral data
was supplied by Monell along with associated metadata of the study group samples. A
sampling of the raw spectral data was first reviewed for chromatographic and spectral
reproducibility across the major urinary peaks, and then for instrumental absolute
baseline and peak intensities to be used for spectral registration and alignment. All
data was then converted to netCDF format and aligned/registered via the MeDDL tool,
resulting in a total of 1166 peaks. Following registration and alignment, the GC/MS data
were analyzed by PCA and the fold change filter as described in Chapter 4. Screening for
group separation via PCA, shown in Figures 22, show clear separation between each of
the treatment groups, indicating that sex, MUP denaturation, and hydration state are
important contributors to the unique volatile profiles. To identify those peaks
responsible for the separation observed via the PCA, we used a combination timebinning (t = 0.1 min) inclusive of only those peaks >200 K absolute intensity and tests for
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Figure 22. Principal component analysis of the treatment groups from showing clear
feature separation.
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(a) Male

(b) Female

Figure 23. The number of binned peaks which displayed 2 fold or greater absolute
intensity changes in each pairwise comparison (from Kwak et.al., 2013).
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fold-change (≥ 2). Once each of these filters was applied to the grouped, global data set,
a Boolean “AND” was added to the resulting filtered peak sets to identify their logical
intersection. fold-change (≥ 2). Once each of these filters was applied to the grouped,
global data set, a Boolean “AND” was added to the resulting filtered peak sets to
identify their logical intersection, resulting in 142 compounds for further investigation
(see Figure 23a-b), which is described elsewhere (see Kwak et.al. 2013).

GC/MS Experimental Example 3: Changes in Volatile Compounds of Human Urine as it
Ages: Their Interaction with Water
A collaborative study was completed using the MeDDL tool with scientists from
Monell Chemical Senses Center (Philadelphia, PA) to investigate changes in the volatile
composition of human urine as it ages. The urinary odors emitted from toilet facilities
and from individuals suffering from either incontinence or metabolic disorders are
perceived as unpleasant. As anecdotal reports suggest that the odor of aged urine is
different from that of fresh urine, using techniques described above for murine urine
this study sought to identify the specific, differential VOCs released from aged human
urine. As described in Kwak et.al. 2013 [119], the urine samples analyzed consisted of a
pooled sample collected from 6 adults (3males and 3 females). From this pooled
sample, six 1 mL aliquots were prepared, with each aliquot placed in a 60 mL glass jar
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and capped. Three of the prepared aliquots were analyzed immediately via SPME based
headspace concentration and GC/MS analysis and served as the "Intact" study group.
The remaining three aliquots were left uncapped in a ventilated chemistry hood for 24h
until nearly dried and served as the "Aged" study group. Raw spectral data was supplied
by Monell along with associated metadata of the study group samples. As described
above, a sampling of the raw spectral data was first reviewed for chromatographic and
spectral reproducibility across the major urinary peaks, and then for instrumental
absolute baseline and peak intensities to be used for spectral registration and
alignment. All data was then converted to netCDF format and aligned/registered via
the MeDDL tool, resulting in a total of 384 peaks. To identify the differential VOCs, the
following filter settings were used: the fold change filter was limited to those peaks with
2-fold or greater change in intensity and the time binning filter parameter was set using
0.1 min bins and inclusive of only those peaks >10K absolute intensity. Once each of
these filters was applied to the grouped, global data set, a Boolean “AND” was added to
the resulting filtered peak sets to identify their logical intersection. Results of the time
binning filter generated 103 discrete peaks and combination with the fold filter (Intact
vs Aged) resulted in 58 differential VOCs. The 58 peaks were identified and a list of the
identified VOCs is provided in Table 1 (from Kwak et.al. 2013).
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Retention time
(min)
1.32
2.15
2.90
3.22
4.06
4.42
4.62
5.59
6.15
6.50
6.88
7.39
8.86
9.36
9.57
9.82
9.92
12.40
12.76
13.02
13.92
15.68
15.83
16.06
18.44
20.45
20.50
20.97
21.39
21.48
21.80
22.77
24.58
26.78
27.47

Base ion

Compound ID

Fold change (Intact -> Aged)

42
43
43
45
43
43
58
43
57
43
43
43
43
43
57
69
71
43
83
72
58
43
112
60
45
74
60
145
110
107
59
42
79
71
107

trimethylamine*
acetone
2-butanone
ethanol
2-pentanone
2-methyl-3-pentanone
2-hexanone
3-hexanone
3-heptanone
3-ethyl-2-pentanone
3-methyl-2-hexanone
4-heptanone
2-heptanone
3-methyl-2-heptanone
6-methyl-3-heptanone
3-methylcyclopentanone
2-methyl-4-heptanone
4-nonanone
3-ethylcyclopentanone
3,5-dimethyl-2-octanone
2-nonanone
4-hydroxy-2-pentanone*
p-menthan-3-one
acetic acid*
propylene glycol*
2-methylbutyric acid*
3-methylbutyric acid*
3,6-dimethylbenzofuran
p-menth-1-en-3-one
a terpene
acetamide*
caprolactone*
dimethyl sulfone*
pentolactone*
p-cresol

5.05
29.66
17.43
11.71
51.83
13.17
8.19
11.04
32.95
4.12
3.74
145.33
12.88
12.81
11.69
14.45
5.42
2.42
22.58
21.16
11.55
2.17
80.09
7.01
14.58
11.19
3.26
15.88
32.04
31.94
2.61
4.41
11.96
7.34
6.59

Table 7. A list of the volatile compounds whose levels changed after the urine samples
were aged [119]. (* indicates the compounds whose absolute intensities increased after
the samples were aged.)
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GC/MS Experimental Example 4: Human Volatile Markers of Age and Ethnicity in
Axillary Odor profiles
A collaborative study was completed using the MeDDL tool with scientists from
Monell Chemical Senses Center (Philadelphia, PA) to investigate human volatile markers
of age and ethnicity in axillary odor profiles. Volatile organic compound biomarker
discovery in humans is especially challenging due to significant variances in diet,
environmental conditions/exposures, and genetics. Thus, creation and validation of
outlier filtering and normalization approaches for spectral data is required for the
differential analysis of many studies involving human subjects, with four approaches
evaluated for this study: Total Ion Current (TIC) based normalization; "Olympic average"

based normalization; outlier filtering; and "Group Distribution" based filtering. Please
note that these are just a few of the filter types available in MeDDL, with a more
complete listing available in Appendix A. In short, TIC normalization involves summing
the intensities of all peaks contained in each file of the spectra and setting that sum as
equal across all files. This approach, however, can be skewed by the presence of high
intensity outliers, thus "Olympic average" based normalization was implemented. In
"Olympic average" based normalization, user defined upper and lower percentiles are
calculated across all of the files using user defined values. This will generate in two
vectors containing percentiles, each with a size of n by 1, where n is the number of
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features. These percentile vectors are used to normalize the intensity values for all ions
across each file. The difference of the original intensities in a file and the lower
percentile value is divided by the difference of the upper and lower percentiles. This
technique will scale down the intensities by several orders of magnitude, but should be
less susceptible to the presence of low/high intensity outliers. Next, the outlier filter,
using an operator defined threshold, removes those peaks that are outside of the range
of the n number of standard deviations from the mean. The user specifies the number
of standard deviations to accept and data outside of this range will not be shown
throughout MeDDL (i.e. this is a display filter, not a data exclusion filter). It should be
noted that as this filter replaces excluded data points from the display with NaNs ("Not a
Number"s), some comparisons and plots, such as PCA, cannot be generated using the
modified data set. The final filtering technique evaluated, and the one utilized for study,
is a similar mean distribution filter to the "outlier" display filter labeled "group
distribution" as currently implemented in MeDDL. In this filter, the means and standard
deviations are calculated across all files for each peak. Each value is checked to ensure
that it is within the user-defined number of standard deviations from the mean, and if
the peak is more standard deviations away then the given threshold, the peak is
excluded from the final peak set.
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In brief, for sample generation by Monell scientists, body odors were collected
from 40 female subjects consisting of N=10 of four ethnic and age group (Young
Caucasian, Young Asian, Older Caucasian, and Older Asian) under a protocol approved
by the University of Pennsylvania Institutional Review Board. Subgroups of these
extracts were combined to form super-donors to eliminate sensory panelists focusing on
individual donors. Prior to skin extraction, subjects were screened via collected SPME
samples prior to formation of super-donors to insure that no donor was an outlier (e.g.,
unusual VOCs such as bromoform from swimming pool water). The raw GC/MS data
from these collected samples was supplied by Monell along with associated metadata of
the study group samples. As described above, a sampling of the raw spectral data was
first reviewed for chromatographic and spectral reproducibility across the major peaks,
and then for instrumental absolute baseline and peak intensities to be used for spectral
registration and alignment. All data was then converted to netCDF format and
aligned/registered via the MeDDL tool to look at inter-age and inter-ethnicity variation
in skin VOCs.

108

Figure 24. Outlier Filter Example. The figure on the top was generated using the
original data and the figure on the bottom was generated after the outliers were
removed. A setting of 1 standard deviation was used in this case. Notice the difference
in scale between the two images.
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A total of 2960 peaks were registered. To identify the differential VOCs, the
following filter settings were used: the fold change filter was limited to those peaks with
2-fold or greater change in intensity and the time binning filter parameter was set using
0.1 min bins and inclusive of only those peaks >100K absolute intensity. A minimum
threshold hold filter was also applied to include only those peaks exceeding an absolute
intensity threshold as low level, trace compounds were not considered relevant to the
funding sponsor (deodorant manufacturer). Next, the group distribution filter,
described above, as applied and excluded all peaks > 3 standard deviations from the
group mean. Once each of these filters was applied to the grouped, global data set, a
Boolean “AND” was added to the resulting filtered peak sets to identify their logical
intersection. Results of the each of the respective filters are shown below, and the
resulting intersection indentified 55 differential VOCs.
PkSet 1 - All Peaks - Size: 2960
PkSet 2 - P-Value <= 0.1 - N-way - Size: 2063
PkSet 3 - Time binning - Delta T: 0.1 Min. Int.: 100000 - Size: 419
PkSet 4 - Fold Change of 2 - Size: 2123
PkSet 5 - Group Intensity Filter of 300000 - Size: 785
PkSet 6 - Group Distribution Filter of 3 - Size: 332
PkSet 7 - Pkset 2 AND PkSet 3 AND PkSet 4 AND PkSet 5 AND PkSet 6 - Size: 55

Results of principal component analysis and unsupervised hierarchical clustering of this
filtered data set are shown in Figure 25 and demonstrated definitive separation
between Asian and Caucasian older age group females.
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Figure 25. Filtered Data from Age and Ethnicity Based Skin VOC Differences.
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Conclusions
Given the unique requirements for the various GC/MS based biomarker studies
described above, comparative analysis, via MeDDL has facilitated efficient of each and
successfully demonstrated not only application and utility of the expanded GC/MS
functionality but also the versatility of the approach. This described methodology is
representative of our analytical pipeline and is applicable to a wide range of VOC and
small molecule based differential profiling and biomarker discovery applications such as
human performance monitoring, odor based biometrics, medical diagnostics, targeted
materials detection, and environmental health and safety investigations, some of which
will be addressed in the following chapter.
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CHAPTER 6. COMPREHENSIVE SAMPLING PIPELINE

Overview
As addressed earlier, studies which require complete characterization of an
unknown, whether it is biologically derived, such as human breath, or environmental, as
in the case of fighter cockpit air, necessitate varied approaches to collection for accurate
and broad-spectrum capture of all potential molecular species present. To address
study requirements for work performed by our laboratory and to complete the end-toend analytical pipeline which was the focus of this research, several "real-world" sample
collection methods were developed and implemented for human breath capture as well
as characterization of the in-flight, pilot air supply in operational combat aircraft, one of
which is presented below. As covered in chapter 1, a variety of methods are available
for volatile sampling. To be able to both quantitate obtained samples and to increase
the likelihood of isolating potential environmental contaminants, thermal desorption
tube based approaches were selected with follow-on analysis being completed utilizing
a modified version of EPA Method TO-17 for monitoring VOCs [120], described below.
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In-Flight Air Quality Sampling
Our laboratory supported investigation of reported issues surrounding the OnBoard Oxygen Generating System (OBOGS) utilized on the F22 and other USAF fleet
aircraft. As part of this effort, a technical solution was developed by our group to
sample and analyze both the cockpit ambient air and OBOGS product air. This involved
placing thermal desorption (TD) tubes in line with the summa canisters already planned
for placement into the OBOGS product line and into the cockpit air. This solution
allowed for a much more complete picture of the chemical make-up of contaminants in
the oxygen supply and cockpit air. The TD tubes provided the ability to capture and
analyze heavier molecular weight chemicals (semi-volatiles) that the summas cannot be
analyzed for. The summas were still necessary to test for very light organics such as
freons and inorganics such as oxygen (O2), carbon monoxide (CO), and carbon dioxide
(CO2). The summas, when timed with a critical aperture, also provided the airflow
through the TD tube so that a known volume was collected for concentration
quantification while avoiding the need for additional connections and equipment to pull
air through the tubes (see Figure 26). Empirical validation of this sampling strategy
showed that a 1 hour collection using the summa canister as a passive pump in line with
the TD tube resulted in a 400ml total volume collection for both. This value was used to
establish corresponding calibration curves for quantitation of detected compounds.
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Figure 26. Air sampling strategy for in-flight collection. Top figure describes airflow
through the TD tube and summa canister. Bottom figure shows engineered solution for
collection of both cockpit ambient air and OBOGS product supply to pilot.
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As stated above, all TD tubes were analyzed using a modified version of
Environmental Protection Agency (EPA) method TO-17 for the determination of toxic
organic compounds in ambient air using active sampling. GC/MS analysis conditions are
listed as follows. TD100 TD auto-sampler parameters: cold trap low temp.: 15°C; Tube
desorption temp.: 310°C; tube desorption time: 10 min; trap purge time: 1.0 min; cold
trap high temp: 315°C for 5 min; split ratio: split-less; trap heating rate: 40°C/s (MAX);
TD flow path: 160°C. Thermo GC Ultra parameters: carrier gas: He; DB-624 column: 60
m x 0.32 mm x 1.80 μm; constant pressure mode: 10 psi; temp. program: 40°C (1 min),
10°C/min to 240°C (20 min) . Thermo ISQ conditions: MS source temperature: 275°C;
transfer line temperature: 230°C; full survey scan mode mass range: 35 to 550 amu.
Daily quality assessment/control procedures involved running a blank with internal
standard and passing tune criteria for bromofluorobenzene (BFB). The internal standard
is a 4 component mix composed of two internal standards (1,4 difluorobenzene and
chlorobenzene-d5), a surrogate (bromochloromethane), and a tuning compound
(bromofluorobenzene). Additionally, prior to processing samples, a laboratory control
sample (LCS) and calibration check verification (CCV) were completed at the mid-point
of the calibration curve. The mid-point calibration curve was 25ppbv. The LCS criterion
is ± 30% of 25ppbv (17.5 – 32.5 ppbv).
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A two pronged approach was used for data analysis. First, a commercial Thermo
Scientific software product, Tracefinder Environmental, Food, and Safety (EFS) version
2.1 was used to store calibration results and generate quantitative/qualitative reports of
TO-17 chemicals detected on the sorbent tubes. This is performed by either matching
sample peaks against a user generated library and calibration curves using a
combination of retention time, quantitative ion, and confirming ions, or as an
unknown/tentatively identified compound via automated NIST11 search. The limit of
detection (LOD) established for most of the TO-17 compounds was established by our
laboratory at 2ppbv. All reports generated by Tracefinder were exported and
summarized into Excel spreadsheets for data consolidation using an in-house Visual
Basic software macro.
The second approach to data analysis was completed through use of the MeDDL
tool (described above). Following registration and alignment, the defined experimental
result groups were processed through a logical combination of the three following data
filters: fold change limiting results to only those peaks which demonstrated at least 2
fold or greater change in intensity; N-Way ANOVA with only those peaks having p < 0.1
significance between groups; and the time binning filter using 0.1 minute bins inclusive
of only those peaks > 200K absolute intensity. Once each of these filters was applied to
the grouped, global data set, a Boolean "AND" was added to the resulting filtered peak
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sets to identify their logical intersection. These reduced data sets were then used for
further manual, statistical, and machine learning comparisons and subsequent
compound identification.
A total of 116 sorties were flown using this sampling strategy with 65 sorties
completed at Langley/Hunter Air Force Base (AFB) and 51 sorties at Joint Base
Elmendorf Richardson (JBER). Note that the majority of the 65 sorties were flown from
Langley AFB. Each sortie generated a set of summa canister and thermal desorption
tube data for both cockpit and OBOGS air samples (Figure 26). Summa canister samples
were analyzed using EPA TO-15 method by Columbia Analytical (ALS-Columbia) located
in Simi Valley, CA. Although specific data is not available for public release, these
investigations identified trace amounts of chemicals in the system, none of which were
above known hazardous concentrations, and were what was expected based on
laboratory testing of the system’s ability to remove contamination. Follow on studies
are planned to determine if the chemicals and concentrations measured are typical
among different fighter airframes vs. those collected and will provide a further
understanding of fighter aircraft air quality baseline.
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Same Sample Subset

Figure 27. Example of in flight data analyzed using the MeDDL tool. Samples consisted
of 414 charcoal filters analyzed by thermal desorption (modified EPA TO-17).
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CHAPTER 7. CONCLUSIONS AND FUTURE DIRECTION

Informatics Pipeline
Through a combination of the base MeDDL registration and alignment
algorithms and the described additional functionality, MeDDL now offers the analytical
chemist the potential for visualizing data in new ways, providing novel insight into the
experimental results, and expediting LC/MS and GC/MS based biomarker discovery.
Modifications to the current implementation of the tool are on-going, with automated
iteration across available “unknowns” for optimization of the hybrid GA parameter
settings planned. The overall framework was rapidly prototyped using MathWork's
Matlab software language and is being translated to the general purpose, platform
independent language, Python, to support wide dissemination of the tool. The MeDDL
tool dramatically reduced manpower costs in our research by providing scaffolding for
the rapid development and verification of new algorithms without the need to create a
large amount of supporting software. MeDDL also offered the potential for staff
scientists to visualize data in new ways, providing novel insight into the experimental
results and facilitating metabolomic biomarker discovery. It should be noted that a
number of tools have recently been proposed in the literature which show great
advancements in metabolomic and LC-MS analysis capability [95-99, 121]. However, the
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MeDDL tool, through its emphasis on visualization, provides unique opportunities by
combining the following: easy use of both GC-MS and LC-MS data; use of both
manufacturer specific data files as well as netCDF (network Common Data Form);
preprocessing (peak registration and alignment in both time and mass); powerful
visualization tools; and built in data analysis functionality.
A new effort to build on the success of the MeDDL tool has been initiated by our
laboratory. Portable GC/MS systems are currently deployed by the DoD in a variety of
situations where the identification of the presence of various VOCs is required for
protection of forces. These systems rely on limited, build in VOC libraries and NIST
reference spectra for identification of individual component compounds and are
typically operated by personnel with minimal technical background. Often times,
materials of interest/concern are actually composed of complex mixtures, whose
relative component ratios are the determining factor required for identification. This
research aims to enhance the capability of the fielded, portable GC/MS systems by
providing rapid, on-site volatile signature recognition. The prototype software system is
envisioned as being composed of two cooperative sub-systems (Figure 28). The offline
learning subsystem will be used in a laboratory setting to assemble an extensible library
of labeled sensor features representing known volatile organic compounds. The labeled
library of VOC’s will seed the second software subsystem; the online VOC analysis
122

system, capable of supporting real time analysis of unknown VOC’s captured using a
field deployable GC/MS system. Both subsystems will exploit algorithms and techniques
developed as part of the MeDDL system described above as well as a probabilistic
pattern recognition scheme previously utilized for processing synthetic-aperture radar
data.

Sampling Future Direction: Exhaled Breath Collection and Biomarker Discovery
Screening for VOC’s in exhaled breath was an important tool during previous
aircraft investigations support by our laboratory. However, there were significant
limitations in the assessment of the data as there were noteworthy levels of VOC’s
observed in some incidents but it was not clear if those compounds were generated
from physiological/ metabolic functions within an individual or from an environmental
exposure that may have occurred during the flight. Additionally, the summa canister
based method previously utilized [122] for sample collection, while very useful for
trapping and analysis of VOC’s with boiling points near that of naphthalene and below,
is not capable of releasing higher molecular weight compounds which compose the
majority of fuels/fluids utilized on aircraft. On-going work by our group seeks to address
the later of these concerns through both the characterization and evaluation of
emerging and novel methodologies for breath collection (see Figure 29) as well as
123
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Figure 29. Gas bag and TD tube time series based breath collection methods
currently utilized by our laboratory and collaborators for on-going breath
biomarker discovery projects.
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identification of breath markers of aviation relevant physiological states such as
hypoxia, fatigue, and stress.
These on-going experiments by our laboratory and collaborators seek to expand
the understanding and ability to detect the complex VOC profiles that are likely to be
present physiologically, occupationally, and in the environment so that we are better
able to monitor and protect personnel in the future. The preceding, developed
informatics tools and processing pipeline have created the foundation for these efforts
and have provided our group a wonderful opportunity to successfully complete much of
the work described.

.
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APPENDIX A. SOFTWARE USER GUIDE
Please note: a complete, online version of the MeDDL user guide is available at:
http://meddl.cs.wright.edu

Peak Data
The Peak Data tab contains the main data table and will also serve as the location of any external
data files that you load. For more information about loading external data, see the entry
on External Data.

Main Buffer
This tab contains the main table that displays a summary of all of the registered peaks in a given
data set. This table allows you to preform a variety of actions on any number of selected peaks.
At the bottom of the table you will see a row of buttons that you will use to further analyze the
data set. These include: Line Plot, Box Plot, PCA, Correlate, Data Table, and Copy. To find a
peak in the Heat Map, simply right-click on it and a green circle will surround that peak. You also
select multiple peaks and right-click on the selection to find multiple peaks in the Heat Map.
Right-clicking once will only highlight peaks while you hold the right mouse button down. To lock
highlighting around a peak, right-click twice.

Line and Box Plot
These plots will display a respective plot for each of the peaks selected. Be advised that you do
not want to select too many peaks at one time because each plot will be displayed in a single
figure. These buttons have two settings associated with them: Plot Display Group and Plot Color
Group. These settings are defined in the Plot Filter tab. The Plot Display Group is the attribute
that you wish to plot and the Plot Color Group is the attribute that you wish to use to split up the
plots by. For example, if your data set has the attributes Strain (containing three possiblities:
AKR, B6, and BALB_B) and MUP Protein (containing two possibilities: Intact and Denatured),
then you can view a plot of the Strain versus MUP Protein by setting your Plot Display Group as
Strain and Plot Color Group as MUP Protein. For a box plot this means that you will have two
separate plots because you have two possible tags under attribute MUP Protein (Intact and
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Denatured) with each containing three boxes along the x-axis (one for each of the tags under the
attribute Strain). For a Line Plot this means that you will have one plot that has each Strain along
the x-axis with each MUP Protein as a different marker.
The Line Plot is unique in that it provides access to the raw spectra data for a particular peak.
You may double click on any of the plotted points in a line plot. This will open a summary window.
Click the Explore button to view a peak in the raw spectra. The window can be dismissed using
the Done button.

PCA
The PCA button will generate a 3D plot of the prinple
components in the data set as well as generate a
variance pareto graph. The PCA uses the last two
attributes in a given data set to generate labels. For
example, if your experiment.ini file contains the
following attributes: [File Subject Strain MUP_Protein],
then you will have a PCA labeled with all possible
combinations of the tags for the last two labels. Again,
if the attribute Strain has three tags: AKR, B6, and
BALB_b, and the attribute MUP_Protein contains two
tags: Intact and Denatured, the PCA will have the labels: Denatured-AKR, Denatured-B6,
Denatured-BALB_b, Intact-AKR, Intact-B6, and Intact-BALB_b. Note that you do not have to have
any peak(s) selected to preform a PCA; the PCA is based off of the entire data set.

Correlate
The Correlate button will take a single selected peak and update the Rank column to contain a
score for the correlation of the peaks in respect to the peak selected. The peak that was used to
correlate from will have a score of 1.0. The correlate function will get the all of the intensities for a
selected peak and pass them into the Matlab corr function. This will return a vector that is the
same size as the main feature vector. This vector will contain Pearson product-moment

144

correlation coefficients for each of the comparisons against the selected feature, which will be
from -1.0 to 1.0. See the corr function for more information.

Data Table
The Data Table button will display a table for the
selected peaks that shows detailed information about
the peak(s) across all of the samples/files. This
detailed information includes data such as mass,
intensity, and time.

Group Filter
The group filter tab allows users to create partitions and groups. For an explanation on partitions
and groups, see the Data Management page. After users have created at least one group, they
can begin to add groups to it. The All partition is a default partition that contains all of the files.

Creating a Partition
To create a partition, simply type a label in the partition text box and click the 'Save Partition'
button. After you create a partition it becomes the active partition on the group filter tab. This
means that any groups you save will be saved within it. To change the active partition, change
the selected partition in the partition combo box.

Creating a Group
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To create a group, you will need to have created a partition (see above). Once you have a
partition, toggle the check boxes under each tag of your data that you wish to include in the
group. Note that if only one field is selected under a given tag, MeDDL automatically inserts that
field into the groups label. Once the check boxes are set for the group, click the 'Save Group'
button. Remember that this group will be added to the active partition (whichever partition is
selected in the partition combo box). You cannot save a group in the All partition. The groups
within a partition must be mutually exclusive.

Outlier Filter
Summary
Removes peaks that are outside of the range of the n number of standard deviations from the mean. This filter inhibits the
use of the PCA functionality. Users specify the number of standard deviations to accept. Data outside of this range will not
be shown throughout MeDDL.

Pseudocode
mu = mean(intensities)
stand = std(intensities)

for i = 1 : number of files
for j = 1 : number of features
if(intensities(i, j) < (mu(j) - (factor * stand(j))) || outlierInten(i,j) > (mu(j) +
(factor * stand(j))))
intensities(i, j) = NaN
end
end
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end

Factor is the user-defined parameter representing the number of standard deviations from the mean to accept.

Theory
The means and standard deviations are calculated across all of the files for each peak. Each value is checked to ensure
that it is within the user-defined number of standard deviations from the mean.The figure on the left is was generated
using the original data and the figure on the right was generated after the outliers were removed. A setting of 1 standard
deviation was used in this case.

Total Ion Current (TIC) Normalization
Summary
Total Ion Current Normalization involves summing the intensities contained in each file of the
spectra. The user selects which file to use as the seed file. The seed file will be used to build the
normalization ratio.

Pseudocode
function computeTICs
TICs = []

for i = 1 : number of features
TICs = [TICs; sum(intensities(i, :))]
end
return TICs
end
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TICs = computeTICs
normailizationRatio =

seedTic / TICs

for i = 1 : number of TICs
intensity(i, :) = normailizationRatio(i) * intensity(i, :);
end

Theory
As you can see in the above pseudocode, a TIC score is calculated for each file in the data by
summing the intensities in said file. This array of TIC scores is returned to a different function that
applies the normalization to the data. The seed TIC is simply the TIC score from the file that the
user selects in a drop down box. The TIC vector becomes the right division of the seed TIC and
TIC vector. That is, each score in the TIC vector becomes the seed TIC divided by the original
TIC score. Note that this makes the normalization ratio for the seed file to be 1; the intensities in
the seed file will remain unchanged. The normalization ratio is applied to all of the intensities
within each file.

Olympic Average Normalization
Summary
The upper and lower percentiles are calculated for all of the features across each file. These
percentiles are then used to normalize the intensity values in each file. Intensity values that
become negative as a result of the normalization are replaced with NaNs.
Enter the upper percentage and lower percentage in the respective text boxes. A setting of 90
and 10 (as shown at the top of this page) will calculate the 10th and 90th percentiles. Thus, the
data will be normalized using the upper and lower 10% of the data.

148

Pseudocode
lower_percentile = prctile(intensity, lower, 2)
upper_percentile = prctile(intensity, upper, 2)

for i = 1 : number of files
normalizedIntensity(i,:) = (intensity(i,:) - lower_percentile(i)) /
(upper_percentile(i) - lower_percentile(i));
end

It is understood that the variables lower_percentile and upper_percentile can be
calculated in one line. For example, the following command would return an array containing the
upper and lower percentiles: prctile(intensity, [lower, upper], 2) Here we break
them up for simplicity.

Theory
The upper and lower percentiles are calculated across all of the files using the user defined
values. This gives us two vectors containing percentiles, each with a size of n by 1, where n is
the number of features. These percentile vectors are used to normalize the intensity values for
across each file. The difference of the original intensities in a file and the lower percentile value is
divided by the difference of the upper and lower percentiles. This technique will scale down the
intensities by several orders of magnitude.
Consider the following Line Plots for the same peak. The left plot shows the original data and the
right plot shows the data that has been normalized using the Olympic Average Normalization
technique. The upper bound of the y-axis for the unnormalized data is 12 x 10^8 and the upper
bound of the y-axis for the normalized data is 350.
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Data Filter
The Data Filter tab contains all of the filtering methods that allow you to down select your data so
that you can focus on significant data. These filters create objects called peak sets. A peak set
can be viewed in the Visualization Tab or classified in the Machine Learning Tab.

P-Value Filter
Summary
The P-Value filter checks for statistical significance using ANOVA, calculating a p-value for each
peak in study. After the p-values are calculated for each peak, a new feature vector is produced
using the user defined p-value threshold (confidence bounds). This feature vector is saved as a
peak set.

Theory
There are two options for the P-Value filter:


N-Way: performs an n-way ANOVA using the Matlab function anovan which accepts all of
the groups in the active partition. The features are down selected to be only from files that are
included in the active partition. The down selected features are sent to anovan. Thus,
features from each file are compared to features from the remaining files.



Pairwise: performs a pairwise ANOVA using the Matlab function anovan iteratively
generating all possible combinations of the groups in the active partition. The indices of the
comparisons relate to the indices of all nonzero elements in a strictly upper triangular matrix,
i.e. 1 to 2, 1 to 3, 2 to 3, etc. Groups are not compared to themselves.
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Time Binning Filter
Summary
The Time Binning Filter allows you to reduce GC-MS data that contains fragments caused by
electron impact.

Pseudocode
while sum(maxIntensities > 0)
maxIndex = max(maxIntensities);

intensityLogical(maxIndex) = 2;
maxIntensities (maxIndex) = 0;

timeCenter = timeAvg(maxIndex);
upper = timeCenter + (deltaT / 2);
lower = timeCenter - (deltaT / 2);

index = find( intensityLogical == 1 AND timeAvg >= lower AND timeAvg
< upper);
intensityLogical(index) = 0;
maxIntensities(index) = 0;
end

Theory
The Time Binning Filter drills down on the data set starting with the most intense peak of the data
set. After the maximum peak is found, the peaks with times within ±t/2 from the time t0 are
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removed from the data, where t is the user defined time parameter and t0 is the time of the most
intense peak in the data set. This process is repeated until all peaks are processed.
The intensities in the 'maxIntensity' array are set to 0 as the data is processed to indicate that
they are of no further interest. The array 'intensityLogical' is a pseudo-boolean array. 0's indicate
features of no interest, 1's indicate potential interest, and 2's indicate an intensity index that is the
maximum within the time window.

Fold Change Filter
Summary
The Fold Change Filter takes the average of each feature across all of the files that are included
in a partition. This produces a group average vector for each group. The average vectors are
divided by each other using right division, left division, a combination of both to produce a fold
value vector (containing a fold value for each feature). Features with fold values that meet or
exceed the user-defined threshold are kept.

Pseudocode
left

= B / A;

right = A / B;

if typeChange == absolute
result = left >= foldChange OR right >= foldChange;
value = max(left, right);
else if typeChange == positive
result = left >= foldChange;
else
result = right >= foldChange;
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Theory
The components of the resulting fold vector are compared to the threshold that the user defines
and only those features that meet or exceed the threshold pass the filter. If there are more than
two groups in the active partition, then pairwise comparisons of all of the groups are generated.
As in the ANOVA filter, the indices of the comparisons relate to the indices of all nonzero
elements in a strictly upper triangular matrix. The disjunction of all of the feature vectors from
each of the pairwise comparisons is generated: features must meet the fold criteria in at least one
fold comparison.
The Fold Change Filter has the options to accept only positive or only negative folds that fulfill the
threshold, where a positive fold is defined as the right division of A and B and a negative fold is
defined as the left division of A and B. Note: we define left division as B(i, j) / A(i, j) and
right division as A(i, j) / B(i, j). See MathWorks for more information. The default setting
is absolute, which accepts a feature if either the left division or right division is greater than the
set threshold. In the case of the absolute setting, the resulting fold value vector will contain the
maximum fold change from either the left division or right division of the average matrices.


Absolute: Calculate the fold using both the left and right division of the pair of matrices. The
fold value will be the maximum for that feature from either matrix.



Positive: Calculate the fold using the right division of the average vectors.



Negative: Calculate the fold using the left division of the average vectors.

Group Intensity Filter
Summary
The Group Intensity filter peaks that have an average intensity greater than the set intensity.
The Strict setting specifies whether or not all of the groups in the partition must pass the filter. If
Strict is used the conjunction of the feature vectors is taken to produce the final peak set.
Otherwise, the disjunction of the feature vectors is taken to produce the peak set.
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Pseudocode
for all samples in the group on the filter tab

if strict is selected
remaining peaks = all the peaks AND peaks with an average intensity
greater than the given absolute intensity

otherwise
remaining peaks = all the peaks ORpeaks with an average intensity
greater than the given absolute intensity

Group Distribution
Summary
Group Distribution filters out peaks that do not fall within the given standard deviation in the group
it is contained in. If the peak is more Standard Deviations away then the given value the peak is
excluded from the final peak set.
The Strict setting specifies whether or not all of the groups in the partition must pass the filter. If
Strict is used the conjunction of the feature vectors is taken to produce the final peak set.
Otherwise, the disjunction of the feature vectors is taken to produce the peak set.

Pseudocode
for all samples in the group

upper limit allowed = group average plus the standard
deviations
lower limit allowed = group average minus standard deviations

154

if strict is selected on the filter tab
filtered peaks = filtered peaks AND intensities that are
less than the upper limit allowed AND intensities that are less than
the lower limit allowed

otherwise
filtered peaks = filtered peaks OR intensities that are
less than the upper limit allowed OR intensities that are less than the
lower limit allowed

Group Separation Filter
Summary
This filter compares all possible pair-wise combinations of the groups. The means of both groups
are calculated, then the difference is found between the mean of every peak in each group. If the
separation of that peak is larger than the given separation value then the peak passes the filter
and depending on strict or loose may or may not be included in the final peak set.
The Strict setting specifies whether or not all of the groups in the partition must pass the filter. If
Strict is used the conjunction of the feature vectors is taken to produce the final peak set.
Otherwise, the disjunction of the feature vectors is taken to produce the peak set.

Pseudocode
for all possible combinations
setA = means for set A
setB = means for set B
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if strict is selected on the filter tab
filteredPeaks = filteredPeaks AND peaks that pass |setA setB| > separationFactor
otherwise
filteredPeaks = filteredPeaks OR peaks that pass |setA setB| > separationFactor

Ratio Filter
Summary
There are two options for this filter, top heavy and singular. Top heavy squares the numerator of
the equation used to find the ratios and singular does not. The filter calculates ratios based on a
formula and returns the given amount of peaks with the highest ratios. The ratio is calculated by
first generating all pair-wise combinations of the groups. Then the Standard Deviation and
average intensities are calculated for each of those groups. Then the ratio is calculated by adding
all the comparison combinations ratios together, ratios are calculate by the absolute value of the
average of set one minus the average of set 2, intensity that is, divided by the standard deviation
of set 1 times the standard deviation of set 2. The statistical significance would be finding peaks
that are tightly formed and separated with respects to intensity.

Top Heavy:

Otherwise:
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Pseudocode
For all pairwise comparisons of the groups

setAMu = means of set A
setAStandardD = standard deviation of set A
setBMu = means of set B
setBStandardD = standard deviation of set B

if top heavy is selected on the filter tab
ratios = ratios + (setAMu - setBMu)^2 / (setAStandardD *
setBStandardD)
otherwise
ratios = ratios + abs((setAMu - setBMu)) / (setAStandardD *
setBStandardD)

pick the n highest ratio peaks

Mass-Time Exclusion Window
Summary
The mass-time exclusion filter allows you to specify an exclusion window of mass and time. This
can be done in two ways: manually or with the heat map. To manually specify an exclusion
window, enter the upper and lower bounds for both mass and time, and then click the Add button.
This will add the window to the table on the right. You may now enter another window and add it
to the table or click the Apply button to generate a peak set that excludes all of the windows listed
in the table. To specify a mass-time exclusion window using the heat map, simply left click and
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drag a selection box around the peaks that you wish to exclude. The coordinates (upper and
lower bounds) of the selected region will be displayed in the text fields for the filter. You may click
the Add button to add the window to the table or modify the upper and lower bounds by typing
them in manually or by drawing a new selection on the heat map.

Manual Selection
Summary
The Manual Selection Filter allows
you to hand select peaks to be
included in a feature vector. This can
be used to include peaks of interest
or to create a mask of peaks that are
extraneous to your study. If the peaks
are of interest, then you can view
them as or logically OR them with
another peak set. If they are
extraneous, you can negate the
feature vector and then AND the
resulting peak set with any other peak set.
Use the Select All/Deselect All to toggle all of the check boxes on or off, respectively. Use the
toggle button to invert the state of all of the check boxes. Finally, the Apply button will generate a
peak set from the selected peaks. All of the columns in the table support sorting, including the
check box column. Left click on the column header to sort in the features in decreasing order.
Click the header again to sort in nondecreasing order.

Peak Set Editor
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The Peak Set Editor allows you to manage peak sets. Use the delete button to delete a selection
of peak sets. The Ctrl key allows you to select more than one peak set. The Delete All button will
delete all of the peak sets.

Machine Learning
MeDDL offers users with several types of classification methods. These methods use Matlab
and Waikato Environment for Knowledge Analysis classifiers. Each of these allow users to
classify data that is internal or external to MeDDL. The internal data classification allows users to
classify the peak sets that they have created using the tool. The external data classification is
currently designed to process a comma separated value file (.CSV). All classification methods
support classifying intensities or ratios of intensities.

Matlab Tree Classifier


Greedy, sequential feature selection algorithm given by the sequentialfs Matlab function.



Uses a forward selection method (need to test the results of a reverse selection method).



If data has been filtered using the fold filter, the data will be sorted so that the fold values are
in descending order.



User specifies the number of features to select and the number of folds for cross validation.



Allows the user to visualize the results by displaying a tree for the desired peak(s) or a bar
graph of the peak(s). The tree is often a simple decision stump, but can have more depth to
it. The bar graphs list the files along the x-axis and show the intensities for each file along the
y-axis.

Pseudocode:
Initialize features vector to zeros
while number of features is less than the requested number
Call the sequentialfs function
**The sequentialfs function uses the functions
ClassificationTree.fit and predict to produce a classification score.
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Add the newly selected features to the features vector
end

As you can see, the sequentialfs method is very important in the classification method. It picks
what features are important by adding them and seeing if classification performance is improved
upon. Classification performance is generated by using the ClassificationTree.fit method. This
method produces a tree. The tree is then used to classify the data using the predict method. The
classifier’s labels are compared to the actual labels to produce a score.

Matlab SVM Classifier


Same greedy, sequential forward selection algorithm as the tree classifier (sequentialfs).



Uses the svmtrain Matlab function.



Allows users to display a bar graph of the selected peak(s) as described above.

The code for the SVM classifier is fairly similar to that of the Tree classifier. The primary
difference is that the sequentialfs method uses the methods svmtrain and svmclassifiy to produce
a score for the feature. Based on this score, sequentialfs decides whether the feature is kept or
removed.

WEKA SVM Classifier


Support vector machine using sequential minimal optimization (SMO) technique.



Uses training and test sets. If no test set is given, the training will be cross validated.



The number of folds for the cross validation is specified by the user.



If a test data set is not supplied, a dialog box is displayed with information about the
classifier’s performance, including a confusion matrix. If a test set is supplied, then a
summary of the accuracy percentages for each of the samples in the test set is displayed.

Pseudocode: If a test set is supplied the program preforms the following:
Load the two files and convert their structures to a .ARFF format
Extract the data and set the class indices
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Instantiate the WEKA classifier
Build the classifier based on the training set
For each instance in the test set
classify the nth instance (this returns a label)
compare the label from the above line and the real label
end
Calculate the accuracy and display a summary dialog

If a test set is not supplied the program performs the following:
Instantiate an instance of Evaluation with the training set
Call the crossValidateModel function of the instance of Evaluation with
the following arguments:
the type of classifier (SMO in this case)
the training set
the number of folds for the cross validation
the options for the classifier
a pseudo-random seed
Display the results in a dialog window
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WEKA SVM Attribute Selector


Support vector machine using sequential minimal optimization (SMO) technique.



The number folds for cross validation and attributes to select are specified by the user.



Accepts one file to use as a training data set.



Displays a dialog box with information about the selected attributes.

Load the file and convert its structure to a .ARFF format
Extract the data and set the class index
Instantiate an instance of AttributeSelection, SVMAttributeEval, and
Ranker
Set the evaluator of the AttributeSelection as the SVMAttributeEval and
the search as the Ranker
Run the attribute selection
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APPENDIX B. PEAK ALIGNMENT VALIDATION

Peak Alignment v2.0 (MeDDL Modification)


Below are typical landmark volatile peaks observed in male murine urine:

Average Mass
(57)
(60), 115, 128
(71),41,93,121

Compound ID
3-heptanone
2-sec-butyl-4,5-dihydrothiazole [SBT]
linalool

Top figure is EI spectra for SBT
Below is diagram defining a unique 2-way match used in MeDDL for alignment
Registration windows (time and m/z) are defined in peak.ini by user prior to registration
Reference LC-MS Sample

LC-MS Sample

t

m
Two-way
Match

Retention Time

Retention Time





Average Time
7.92-8.51
14.72-15.32
16.97-17.72

One-way
Match

Two-way
Match

mass (m/z)

mass (m/z)
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Example Study Details:
Date range of raw files: 1/20/2011 – 10/4/2011
N=151
Exposure group date of analysis:
 FT1
1/20/2011
 BP1
1/31/2011
 BM2
2/16/2011
 BP2
2/23/2011
 YP2
8/6/2011
 CTR1
8/24/2011
 BA2
9/11/201
 BA3
10/1/2011
Experimental Time Shift:
To accurately register this study, taking into account the 9 month length of analysis, it is
necessary to determine time and mass variation of a subset of the above landmark peaks in
murine urine. Samples from the C (48hr) timepoint will be used as these are present in each
exposure group tested.
Samples used for peak landmark comparison:
FT1_DBA_17_C
BP1_DBA_25_C
BM2_DBA_41_C
BP2_DBA_49_C
YP2_DBA_57_C
CTR1_DBA_65_C
BA2_DBA_73_C
BA3_DBA_81_C
d:\data\...\raw files\yp2_dba_57_c
urine

8/8/2011 12:11:32 PM

Mouse#57

RT: 0.00 - 80.03
2.45
100

13.32 14.72

50

4.35

0
100

9.15 11.43

19.38 22.88
25.09 30.02

35.85

42.63 44.43

52.40 57.82 59.76

66.05

74.25 76.17

2.45

13.35 14.76

50

4.36

0
100

9.19

22.92 27.07 30.07 32.04

16.38

40.55 42.35 46.62

54.35 58.02 62.03 64.00

70.60 72.40

76.98

2.68

50

13.90

4.79
6.56

0
100

11.95

15.30

23.45 24.49 30.59

16.87

36.46 40.57 43.52

47.68 50.40 53.71 56.82 62.46 64.51

70.71 73.99 77.33

2.67

13.90 15.30
50

4.78
9.67 11.94

0
100

23.45 26.83 30.59

16.87

36.46

37.43 43.68 47.21 50.13 53.46 57.36 62.33 64.89 69.23 73.51 77.08

2.69

50

4.82
6.61

0
100

10.93

13.95
15.32
19.95 23.47 25.40 30.60

36.48 39.37 43.43 46.84 50.93 53.58 57.06

63.67

71.40 73.56 76.39

2.44
13.33

50

4.35

0
100

14.75

9.16

16.42

22.91 23.89 30.05

35.87

42.01 44.27

52.21 54.56

60.06 62.88

70.67 74.43 76.69

2.69

50

4.79
9.68
6.55

0
100

13.88
19.92

23.45 28.81 30.60

36.47 38.30 42.55

47.66 50.30 53.80

59.10

65.26 67.84

72.98

77.15

2.45
13.35 14.76

50

4.36

9.19

5

10

0
0

22.92 27.07 30.07 32.04

16.38
15

20

25

30
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35

40.55 42.35 46.62
40
Time (min)

45

54.35 58.02 62.03 64.00
50

55

60

65

70.60 72.40
70

76.98
75

NL:
1.58E8
TIC MS
BA2_DBA_7
3_C
NL:
2.83E8
TIC MS
yp2_dba_57
_c
NL:
1.40E9
TIC MS
bm2_dba_41
_c
NL:
1.78E9
TIC MS
bp1_dba_25
_c
NL:
1.08E9
TIC MS
bp2_dba_49
_c
NL:
1.93E8
TIC MS
ctr1_dba_65
_c
NL:
2.25E9
TIC MS
ft1_dba_17_
c
NL:
2.83E8
TIC MS
yp2_dba_57
_c

80

3-Heptanone
d:\data\...\raw files\bm2_dba_41_c
urine

2/18/2011 12:26:10 PM

Mouse#41

RT: 7.77 - 9.38
8.46

100
7.86

0

7.94 7.98

8.04 8.08 8.13

8.22

8.27

8.34
8.45

100
7.84

0

7.94

8.00 8.03

8.13 8.18 8.22

8.34 8.37
8.47

7.84 7.89

7.95 7.98 8.03 8.07

8.16

8.24 8.29 8.32

8.39
8.51

100
7.95

7.87

0

0

8.08 8.13

7.79 7.84

8.27 8.32 8.35 8.41

8.35

8.45

8.51

8.34

8.21 8.24

8.46

8.51

7.93
8.01

7.79 7.84

8.10

8.33

8.16 8.19 8.24

8.46

8.50

7.92

100
0

8.19

7.93

100
0

8.12

8.11 8.13 8.18 8.22 8.26

7.79 7.83

100
0

8.05

7.93

100

8.02 8.06 8.12 8.15

7.79
7.8

7.9

8.0

8.1

8.24
8.2

8.32
8.3

8.49
8.37
8.4

8.5

9.04

Time (min)

Current registration settings/algorithm not accurately capturing and registering peak (see
below scatterplot).
6

5

MS (56.9885) RT(8.488) P(18)

x 10

FT
BP
BM
4.5

YP
CTRL
BA

4

3.5

3
Maximum Intensity

Relative Abundance

100
0

NL:
8.32E6
m/z= 56.50-57.50
MS
8.64 8.68
8.75 8.78
9.18 9.21
9.29 9.32
FT1_DBA_17_C
NL:
7.59E6
m/z= 56.50-57.50
9.04
MS
8.85
8.66
8.98
8.71 8.76
9.17 9.19
9.28 9.33
bp1_dba_25_c
NL:
1.02E7
m/z= 56.50-57.50
8.70
8.81
8.87
8.95 9.00 9.05
9.16 9.20 9.23 9.30 9.34 MS
bm2_dba_41_c
NL:
9.86E6
m/z= 56.50-57.50
9.09
8.68 8.72
8.80
8.91
8.96
9.17
9.24 9.27
9.35 MS
bp2_dba_49_c
NL:
7.11E5
9.19
9.30 9.36 m/z= 56.50-57.50
8.60 8.66
8.75 8.78 8.84 8.90 8.95 9.00 9.05 9.12
MS
yp2_dba_57_c
NL:
6.22E5
9.16
m/z= 56.50-57.50
8.63
8.70 8.75 8.81
9.29 9.32
8.88 8.93 8.99 9.04 9.10
MS
ctr1_dba_65_c
NL:
6.90E5
8.56 8.62 8.66 8.72
8.80
8.88 8.92 8.95
9.04 9.09 9.15 9.17
9.28 9.32
m/z= 56.50-57.50
MS
ba2_dba_73_c
NL:
5.11E5
8.64 8.68 8.73
9.28 9.30
8.84 8.86 8.89
8.99
9.07 9.10 9.14
9.37
m/z= 56.50-57.50
MS
8.6
8.7
8.8
8.9
9.0
9.1
9.2
9.3
ba3_dba_81_c

8.86

2.5

2

1.5

1

0.5

0

2011 01 21

2011 01 31

2011 02 18

2011 02 25
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2011 08 08

2011 08 26

2011 09 13

2011 10 03

SBT
D:\Data\...\Raw Files\FT1_DBA_17_C
urine

1/21/2011 2:04:57 PM

Mouse#17

RT: 14.12 - 16.29
15.30

100
50
0
100

14.19 14.25

14.38 14.46

14.56

14.68 14.74

14.86

14.94 15.01 15.07 15.14

15.55 15.60 15.66 15.74

15.85 15.89 15.97 16.05

16.21

15.30

50
14.22 14.28

Relative Abundance

0
100

14.38 14.43

14.54

14.67

14.78 14.89 14.93

15.06 15.13

15.53 15.60 15.65

15.82 15.87 15.94 16.01 16.08

16.20

15.30

50
0
100

14.19 14.24 14.28

14.42

14.50 14.58

14.73 14.78

14.89 14.94

15.08 15.12

15.52 15.58 15.66 15.74

15.85 15.91 15.99

16.15 16.22

15.32

50
0
100

14.14

14.27 14.34

14.43 14.48

14.62

14.76
14.76

14.86 14.92

15.07

15.19

15.55 15.59

15.71 15.76 15.86 15.90

16.02 16.06

16.18 16.27

14.16

14.28 14.35 14.40 14.47 14.54

15.02 15.10 15.16 15.24 15.30 15.40 15.45 15.55 15.60

15.76 15.82

15.98

16.12 16.17

14.75

50
14.23

0
100

14.33 14.39

14.49 14.55

14.97 15.03

15.16 15.21

15.34 15.40 15.49 15.54

15.64

15.77 15.81

15.93

16.04 16.08

16.26

14.72

50
0
100

14.18 14.24

14.35

14.48 14.53 14.58

14.97 15.01 15.11

15.22 15.27

15.43

15.56

15.70 15.75

15.90 16.00 16.08 16.14 16.20

14.72

50
0

14.17
14.2

14.25

14.34

14.3

14.48
14.4

14.5

14.59
14.6

14.95 15.01 15.06 15.14 15.23 15.29 15.38
14.7

14.8

14.9

15.0

15.1

15.2
15.3
Time (min)

15.4

15.49
15.5

15.57 15.63
15.6

15.73
15.7

15.82
15.8

15.92 15.98
15.9

16.0

16.11 16.15
16.1

NL: 1.29E8
m/z=
114.50-115.50
MS bm2_dba_41_c
NL: 9.06E7
m/z=
114.50-115.50
MS bp2_dba_49_c
NL: 3.64E7
m/z=
114.50-115.50
MS yp2_dba_57_c

50
0
100

NL: 2.60E8
m/z=
114.50-115.50
MS
FT1_DBA_17_C
NL: 2.87E8
m/z=
114.50-115.50
MS bp1_dba_25_c

16.25

NL: 3.45E7
m/z=
114.50-115.50
MS ctr1_dba_65_c
NL: 2.23E7
m/z=
114.50-115.50
MS ba2_dba_73_c
NL: 2.46E7
m/z=
114.50-115.50
MS ba3_dba_81_c

16.2

Linalool
D:\Data\...\Raw Files\FT1_DBA_17_C
urine

1/21/2011 2:04:57 PM

Mouse#17

RT: 16.86 - 18.53
100
50
0
100
50

Relative Abundance

0
100
50
0
100
50
0
100
50
0
100
50
0
100
50
0
100
50
0

NL:
8.86E5
m/z= 92.50-93.50
MS
17.88
18.16 18.21
18.30
18.41 18.46
18.00 18.06
16.90
16.97
17.05
17.15 17.19
17.29 17.34 17.43 17.49 17.54
FT1_DBA_17_C
17.65 17.67
NL:
17.71
3.88E5
m/z= 92.50-93.50
17.79
18.35 18.38 18.46
17.85 17.89
18.08 18.15 18.19 18.27
18.01
MS
17.51
17.44
16.88 16.95 17.01 17.06 17.11 17.18
17.27
17.39
bp1_dba_25_c
17.69 17.72
NL:
2.27E5
17.78
m/z= 92.50-93.50
17.83 17.88
18.00
18.19 18.27 18.32 18.37
18.08
18.46
17.20 17.24 17.31
17.56
17.40 17.45
16.93 16.96 17.04 17.10
MS
bm2_dba_41_c
17.72 17.74
NL:
4.03E5
m/z= 92.50-93.50
17.93
18.02
18.31
18.12 18.18 18.22
18.43 18.47
17.34
17.51 17.59
16.90
16.99 17.03 17.12 17.17 17.20 17.25
17.44
MS
bp2_dba_49_c
17.00
NL:
1.67E5
17.60 17.67
17.13 17.17
17.27 17.30 17.39 17.46 17.51
17.78
17.88 17.92 17.96
18.07 18.13 18.20 18.27 18.31 18.37 18.44 18.49 m/z= 92.50-93.50
16.90
MS
16.98
yp2_dba_57_c
17.00
NL:
9.85E4
17.05 17.10 17.21 17.25
17.44 17.50
17.61 17.66
17.74 17.78 17.87 17.94 17.98
17.34
18.07 18.11 18.17
18.26 18.30 18.36
16.86
18.50 m/z= 92.50-93.50
MS
16.97
ctr1_dba_65_c
NL:
7.29E4
17.61
17.85 17.93 17.97 18.01
17.10 17.16 17.23
17.30
17.39 17.44 17.50
17.71 17.75
18.24 18.27
18.12
16.86
18.35
18.42
18.51 m/z= 92.50-93.50
MS
16.97
ba2_dba_73_c
NL:
17.02
8.27E4
17.05
18.26 18.28 18.34
17.73 17.79
17.19 17.25
17.36 17.40 17.47 17.53 17.57 17.61
17.87
17.96 18.02 18.05
18.16
18.50
m/z= 92.50-93.50
16.9
17.0
17.1
17.2
17.3
17.4
17.5
17.6
17.7
17.8
17.9
18.0
18.1
18.2
18.3
18.4
18.5 MS
ba3_dba_81_c

17.69

Time (min)
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Delta-T Histogram approach: Calculation of chromatographic region/binned (delta T –
Chromatographic time shift) histograms
 Generate discrete histograms of the time deltas for misaligned peaks (comparing reference
image to new candidate images)
 Only unique, 2-way peak matches are utilized by MeDDL for generating alignment via
polynomial fit.
 Purpose of new function is to down-select identified unique two-way matches for
generation of accurate curve for polynomial fit capable of aligning significant time shifts
observed.
 Utilized both static and dynamic deltaT bin sizes (in number of peaks and time windows)
 Initially considered discarding first few minutes due to compounds eluting irrespective of
column properties (bimodal deltaT distribution noted).
 DeltaT histograms demonstrated logarithmic increase in time shift over chromatographic
time (NOT linear)
 Resulting alignment correction (polyfit) using deltaT distributions limited to third order
polynomial as this showed best results
Below are two examples of the misalignment from different time regions:
D:\Data\...\Raw Files\BA2_DBA_73_C
urine

RT: 0.80 - 12.37
NL:
1.58E8
TIC MS
BA2_DBA_
73_C

2.45

100
90

70

Relative Abundance

Relative Abundance

80

60
50
40
4.35

30
20
10

1.78

0
100

2.94 3.21

6.03
7.16 7.93
4.59 4.79 6.51

11.43

9.15
8.92

10.48

90
80

80
60
40
7.93

60

8.92
8.50

7.28

70

NL:
2.14E7
TIC MS
BA2_DBA_
73_C

9.15

20
NL:
1.08E9
TIC MS
bp2_dba_4
9_c

Mouse#73

11.43

100

11.98

2.69

9/13/2011 12:03:57 PM

RT: 7.23 - 12.70

9.24

10.29

10.48

11.26

11.98

12.51

0

NL:
1.50E8
TIC MS
bp2_dba_4
9_c

10.93

100
80
60

50
40

4.82

8.51

40

10.67

9.71

11.45

11.97

30
20
10

1.37

2.29

0
1

2

3.10 3.49
3

4

5.29

6.10
5

8.51

7.44

6
7
Time (min)

20

10.93
9.71 10.67 11.45

6.61

7.44
7.70 7.78

9.09 9.49

9.81 10.41

11.03

11.85

12.48

0
8

9

10

11

8

12
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9

10
Time (min)

11

12

Observed Delta T Between Misaligned Chromatograms

Observed Delta T Between Misaligned Chromatograms
0.8

0.8

0.7

0.7

0.6

0.6
y = 0.1294ln(x) + 0.2113
R² = 0.5994

0.4

Delta T

Delta T

y = 0.0075x + 0.4243
R² = 0.4007

0.5

0.5

Shift
Log. (Shift)

0.3

0.4

Shift
Linear (Shift)

0.3

0.2

0.2

0.1

0.1

0

0
0

5

10

15

20

25

30

35

0

40

5

10

15

20

25

30

35

40

Chromatographic Time

Chromatographic Time

Generated DeltaT histograms, static 2 minute time window:
2 Sample histogram alignment example:
RT: 6.54 - 9.35
6.61
100

NL:
1.13E7
m/z=
56.5057.50 MS
BP2_DBA_
49_C

8.51

90

Relative Abundance

80
70

49C

60
50

pk186

40
30

9.09

20
6.87

10
6.71

7.04

0
100

7.13 7.21 7.25

7.43 7.48

7.63 7.72 7.77

7.95
7.87
7.93

8.05

8.19

8.68 8.72 8.80 8.91

8.32 8.39

9.17 9.24
NL:
6.90E5
m/z=
56.5057.50 MS
ba2_dba_7
3_c

90

pk175

80

pk911

pk907

70
60
50

pk188

30
20

8.50

7.16

10
0

pk920

Pk923

40

6.62
6.6

6.78 6.82 6.84 6.89
6.8

7.0

7.13

7.18
7.24 7.28
7.39 7.48
7.2

7.4

7.60 7.65 7.73
7.6

7.8

8.01 8.10
8.16
8.0
Time (min)
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8.2

8.33

8.46
8.4

8.56
8.6

8.72 8.80 8.88 8.92 9.04
8.8

9.0

9.15 9.17
9.28
9.2

73C

Optimization of number of bins per histogram would be required. 10 appears to provide
adequate resolution for this example.
10 bins / 0.58 / matches with observed shift

15 bins / 0.6
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70

50

60

50

40

40

30
30

20
20

10
10

0
-0.8

-0.7

-0.6

-0.5

-0.4

-0.3

-0.2

-0.1

0

8 bins 0.64

0
-0.8

0.1

-0.7

-0.6

-0.5

-0.4

-0.3

-0.2

-0.1

0

0.1

Correlation of unique 2 way matches (i.e. 22.8 / 23.46)

60

40

50
35

30

40

X = 22.88
Y = 23.46
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30
20

15
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10
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0
-0.8

0

-0.7

-0.6

-0.5
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0

0.1

0
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5

10

15

20

25

30

35

40

Static 5 minute window:
2-7minutes
30

70
60

Composite DeltaT Histogram

20

50
40
30

10

20
10
0
-0.8

-0.6

-0.4

-0.2

0

0.2

0
-0.6

-0.5

7-12minutes

-0.4

-0.3

-0.2

12-17minutes

2

15

1.5

10

1
5

0.5
0

-0.58

-0.57

-0.56
-0.55
17-22minutes

-0.54

-0.53

0
-0.8

15

15

10

10

5

5

0
-0.7

-0.65

-0.6

-0.55 -0.5
27-32minutes

-0.45

-0.4

-0.35

8

0
-0.7

-0.7

-0.6
-0.5
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-0.4

-0.3

-0.65

-0.6
-0.55
32-37minutes

-0.5

-0.45

3

6

2

4
1

2
0
-0.8

-0.7

-0.6

-0.5

-0.4

-0.3

0
-0.64 -0.635
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-0.63 -0.625 -0.62 -0.615

-0.61 -0.605




To attempt to increase accuracy in polyfit and reduce bias in generated deltaT bins due to
the peak density, bin sizes were next evaluated dynamically.
The bin time window increased using defined steps until a bin minimum peak count is
achieved (both parameters user specified in the peak.ini).
[HistStep PeaksPerHist]
0.01 10






Below figures show example of dynamic bins and resulting corrective polynomials/residuals.
Note that in the 0-2.6 min window, a single cluster of 20 peaks exceeds the 10 peak
threshold for bin creation.
This is due to the “hard ionization” EI method utilized causing a large number of fragment
peaks generated for a single compound (example below)
Thus a single bin step can incorporate this molecular “bundle”, and induce the bias/bimodal
distributions noted in the deltaT histograms.

5.5

data 1
quadratic
cubic

5
4.5
4
3.5
3
2.5
2
1.5
1
0.5



1

1.5

2

2.5

3

3.5

4

4.5

5

Therefore, for GC/MS by EI, we MUST utilize a variant of our time binning filter algorithm in
the down-selection of unique two way matching peaks to be used for polynomial fitting as
the EI fragmentation patterns too heavily weight individual molecular peaks.
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data 1
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residuals
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0.2

0
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d:\data\...\raw fi l es\bp2_dba_49_c
uri ne

2/25/2011 1:48:06 PM

M ouse#49

Relative Abundance

RT : 3.73 - 5.14
NL:
4.69E7
TIC M S
B A 2_DB A _7
3_C

150
4.35

100
50
0

3.74

3.81

3.99

4.06

4.15

4.20

4.53

4.59

4.74

4.79

4.91

4.97

5.07
NL:
3.75E8
TIC M S
bp2_dba_49_
c

150
4.82

100
50
0

3.80

3.85

3.8

4.00

bp2_dba_49_c #577 RT : 4.82
T : + c Ful l m s [41.00-400.00]

Relative Abundance

4.23

4.29

4.2

AV: 1

4.41

4.54

4.4
T i m e (m i n)

4.63

5.07

4.68

4.6

4.8

5.0

NL: 5.11E7

126.00

100
80

4.15

4.0

57.00

60
69.02

40

110.97
96.95

20
128.07

0
50

100

150

190.93

207.08

265.15

200

250
m /z
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280.98

294.82
300

334.27

355.33

350

384.07
400

Time Binned Down Selection of Unique Two Way Matches:
 Utilizes a modification of the time-bin algorithm originally created as a filter for EI spectra
differential profiling described as follows: a supplementary time-binned, fold change
algorithm which was labeled as “hard ionization”. In the “hard ionization” method, the
analyst specified both a time window and peak intensity threshold for comparison. The
comparison then proceeded as follows: an averaged composite image of each user-defined
comparative group was generated; the most intense peak from all comparative groups was
evaluated across all aligned images using criteria specified; once the comparison was
completed, this “time slice” based upon the peak apex ± ½ of the specified time window is
removed from further analysis and the next most intense set of peaks are compared.
 Application of time binning in the matched peak set allows for the logical and
chromatographically distributed down-selection of the most predominant (intense) unique
two-way matching peaks and avoids the weighting issues observed in deltaT binning (artifact
of EI).
 This algorithm may be turned on/off and the time window parameter specified by the user
prior to registration in the peak.ini (below).
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RT: 0.97 - 3.06
NL:
1.58E8
TIC MS
BA2_DBA_
73_C

14

Relative Abundance

12
10
8
6
1.78

1.39

4
2

1.71

1.25

2.13 2.21

2.94
2.85

2.65

Time1.18
Binning 2 Sample Validation:
NL:
2 Sample Validation: Approximate 0.6min shift easily 1.08E9
observed.
14
TIC MS
bp2_dba_4

Note
that
previous
images
show
linear
fitting
inadequate
for proper alignment.
9_c
12
 Binning studies show that this shift increased rapidly in the first 4 minutes.
10
 Due to observed behavior, alignment of the first few chromatographic minutes likely most
8
problematic
6
 No significant
peaks
observed after
37 minutes
2.29
1.37
1.82 1.92
0

4
1.32

2

2.10

1.48

2.40

2.55

Example registered 1.73
peak table used for verification:

0

1.00

1.0

1.21
1.2

1.4

1.6

1.8

2.0
2.2
Time (min)

2.4

2.6

2.8

3.0
Intensity

Pk74

Pk7

Pk57

Pk559

Pk287

Pk893

BP2_DBA
1 _49_C
BA2_DBA
2 _73_C
BP2_DBA
1 _49_C
BA2_DBA
2 _73_C
BP2_DBA
1 _49_C
BA2_DBA
2 _73_C
BP2_DBA
1 _49_C
BA2_DBA
2 _73_C
BP2_DBA
1 _49_C
BA2_DBA
2 _73_C
BP2_DBA
1 _49_C
BA2_DBA
2 _73_C

2011 02
25
2011 09
13
2011 02
25
2011 09
13
2011 02
25
2011 09
13
2011 02
25
2011 09
13
2011 02
25
2011 09
13
2011 02
25
2011 09
13

Unaligned Time

Matched Time

BP

DBA

49

48 A_UNSTR

155

43.9281

1.63E+07

1.3185

1.3105

43.9268

23593

BA

DBA

73

48 A_UNSTR

147

43.9502

1828209

1.2524

1.4042

43.9489

8690

BP

DBA

49

48 A_UNSTR

161

58.0244

2.29E+07

1.3685

1.3604

58.0234

24580

BA

DBA

73

48 A_UNSTR

164

58.0181

2732492

1.3932

1.5575

58.0148

9858

BP

DBA

49

48 A_UNSTR

216

42.9806

2.63E+07

1.8245

1.8159

42.9793

33562

BA

DBA

73

48 A_UNSTR

202

42.9901

2289576

1.7083

1.8995

42.9891

12836

BP

DBA

49

48 A_UNSTR

228

206.9607

2.26E+07

1.924

1.9153

206.9314

35821

BA

DBA

73

48 A_UNSTR

211

206.9519

2583981

1.7828

1.9802

207.0146

13847

BP

DBA

49

48 A_UNSTR

272

71.9965

9676288

2.2885

2.2796

71.9952

44684

BA

DBA

73

48 A_UNSTR

253

72.0009

215830

2.1313

2.357

71.9969

19575

BP

DBA

49

48 A_UNSTR

286

56.0603

291657

2.4047

2.3956

56.0593

47465

BA

DBA

73

48 A_UNSTR

263

56.0837

52237

2.2141

2.4463

56.0806

-20800
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Time Binning 8 Sample Validation:
 Subset of sample validated: Limited to 8 by Thermo Xcalibur in number of spectral overlays
possible
 Shifts similar to 2 sample validation

d:\data\...\multitest\bp2_c57_53_c
urine

2/25/2011 8:24:44 PM
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4.82
_c
NL:
1.80E8
4.36
TIC MS
16.91
ba2_c57_79
_c
11.99
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5
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66.72 71.59
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15.32
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19.95
30.60 36.48 39.37 46.84 52.17
63.67
73.56
_c
13.96
NL:
2.68
7.26E8
15.33
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4.82
bp2_dba_50
6.60
19.96 23.47 30.60 36.48 43.44 47.66 52.99
65.27 68.61
_c
2.69
NL:
9.36E8
13.94 15.34
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_c
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60.50 64.47 72.34
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0
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13.95

4.83
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Time (min)
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80



The 0-4 minute time range arguably best illustrates the power of this method for EI GC/MS
alignment (note peaks at 1.37 and 1.82 minutes).
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Please note response of pk437 and pk1892 (4.82 min).



Registration of the leading shoulder can be eliminated through the time binning filter with a
0.1 min window (verified)
Not artifact, as new registration algorithm only down-selects 2 way matches used for
alignment and does not affect peak detection.
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52

48 A_UNSTR

577 126.0429

4.23E+07

4.8172

4.794 126.0446

-116493

BA

C57

78

48 A_UNSTR

521 125.9819

6808069

4.3529

4.7263 125.9872

-65118

BA

C57

79

48 A_UNSTR

521 126.0349

6433989

4.3529

4.7304 126.0305

-64539

BA

DBA

73

48 A_UNSTR

521

125.983

6293168

4.3529

4.7294 125.9796

-57477

BA

DBA

74

48 A_UNSTR

523 125.9842

8536832

4.3695
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Peak Shoulder Registration:
Increasing baseline to 300K absolute eliminates registration of shoulder peaks.
Old registration parameters

New registration parameters

Resulted in 2422 peaks detected
[minIval]
25000
[HotPeakTH]
50000

Resulted in 918 peaks detected
[minIval]
100000
[HotPeakTH]
300000
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D:\Data\...\MultiTest\BP2_C57_53_C
urine

2/25/2011 8:24:44 PM
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_c
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NL:
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ba2_c57_78
_c
NL:
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_c
NL:
1.58E8
TIC MS
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_c
NL:
2.17E8
TIC MS
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_c

5.5

Additional manual examination of right combined spectra demonstrate that use of above
peak.ini parameters resulted in no missed significant peaks and no duplicate registration of
leading/tailing edges.
Conclusion: no overlap in peak registration (shoulders) for same mass seen when baseline
increased to 300K absolute.
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APPENDIX C. PEAK NORMALIZATION

Normalization Test (8 Sample)
Purpose: To evaluate the effect of normalization on stress study data (8 sample example)
Example Study Details:
Date range of raw files: 1/20/2011 – 10/4/2011
N=151
Exposure group date of analysis:
 FT1
1/20/2011
 BP1
1/31/2011
Group A
 BM2
2/16/2011
 BP2
2/23/2011
 YP2
8/6/2011
 CTR1
8/24/2011
Group B
 BA2
9/11/201
 BA3
10/1/2011
Decreased Sensitivity:
To accurately analyze this study, normalization of some type is required. Following the 6 month
down-time of Feb – Aug, a significant decrease in sensitivity was noted. Samples from the C
(48hr) timepoint will be used for validation as these are present in each exposure group tested.
Samples used for peak landmark comparison:
FT1_DBA_17_C
BP1_DBA_25_C
BM2_DBA_41_C
BP2_DBA_49_C
YP2_DBA_57_C
CTR1_DBA_65_C
BA2_DBA_73_C
BA3_DBA_81_C
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RT: 0.00 - 80.03
2.69
100

NL:
1.00E9
TIC MS
4.83
15.32
bp2_c57_53
11.99
23.47 30.60 36.49 43.39 47.45 53.52
_c
66.72 71.59
NL:
2.69
1.08E9
13.95
TIC MS
4.82
15.32
bp2_dba_49
19.95
30.60 36.48 39.37 46.84 52.17
63.67
73.56
_c
13.96
NL:
2.68
7.26E8
15.33
TIC MS
4.82
bp2_dba_50
6.60
19.96 23.47 30.60 36.48 43.44 47.66 52.99
65.27 68.61
_c
2.69
NL:
9.36E8
13.94 15.34
TIC MS
4.83
bp2_dba_52
11.99
16.91 23.47 30.60 36.49 40.40 45.98 51.85
65.92 70.59 78.85 _c
2.45
NL:
1.84E8
13.32 14.72
TIC MS
4.36
ba2_c57_78
6.02
16.34 22.89 30.02
32.50 42.76 47.03
59.67 66.15 72.22
_c
2.45
NL:
1.80E8
13.32 14.72
TIC MS
4.35
ba2_c57_79
22.88
30.02 34.85 42.41 46.10
59.45 68.21 72.33 78.66 _c
2.45
NL:
1.58E8
13.32 14.72
TIC MS
ba2_dba_73
11.43
19.38 22.88 30.02 35.85 42.63 46.08
59.76 66.05
76.17 _c
2.45
NL:
2.17E8
14.73
TIC MS
4.37
ba2_dba_74
6.03
19.38 22.89 30.02 35.85 42.32 46.57
60.50 64.47
72.34
_c

13.95

50
0
100
50
0
100

Relative Abundance

50
0
100
50
0
100
50
0
100
50
0
100
50
0
100
50
0
0

10
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40
Time (min)

50
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70

80

Summary of major peaks:
Numbers for UnNorm, TIC Norm, and Olympic represent the relative fold change between
analysis time groups (A/B) referenced above.
UnNorm
R.T.
Peak
5.51
2.7
126
6.18
4.78
152
6.3
6.54
153
6.56
13.93
141
4.57
15.32
60
5.31
19.95
131
Olympic used 80/20%

TIC
Norm
1.09
1.03
1.04
1.11
1.29
1.1

Olympic
1.15
1.02
1.02
1.06
1.35
1.13
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